Medical College of Wisconsin
CTSICores SearchResearch InformaticsREDCap

Douglas B. Evans MD

Douglas B. Evans MD

Chairman, Professor

Institution: Medical College of Wisconsin
Department: Surgery
Division: Administration
Program: General

Member of the Cancer Center


Publications

  • Analysis of free-form radiology dictations for completeness and clarity for pancreatic cancer staging. (Marcal LP, Fox PS, Evans DB, Fleming JB, Varadhachary GR, Katz MH, Tamm EP) Abdom Imaging 2015 Apr 24: PMID: 25906341
  • The Effect of Thyroiditis on the Yield of Central Compartment Lymph Nodes in Patients with Papillary Thyroid Cancer. (Lai V, Yen TW, Rose BT, Fareau GG, Misustin SM, Evans DB, Wang TS) Ann Surg Oncol 2015 Apr 8: PMID: 25851341
  • Revised american thyroid association guidelines for the management of medullary thyroid carcinoma. (Wells SA Jr, Asa SL, Dralle H, Elisei R, Evans DB, Gagel RF, Lee N, Machens A, Moley JF, Pacini F, Raue F, Frank-Raue K, Robinson B, Rosenthal MS, Santoro M, Schlumberger M, Shah M, Waguespack SG) Thyroid 2015 Jun;25(6):567-610 PMID: 25810047
  • Neoadjuvant therapy for localized pancreatic cancer: support is growing? (Evans DB, Ritch PS, Erickson BA) Ann Surg 2015 Jan;261(1):18-20 PMID: 25599323
  • Low 24-hour urine calcium levels in patients with sporadic primary hyperparathyroidism: is further evaluation warranted prior to parathyroidectomy? (O'Connell K, Yen TW, Shaker J, Wilson SD, Evans DB, Wang TS) Am J Surg 2015 Jul;210(1):123-8 PMID: 25595714
  • Additional support for neoadjuvant therapy in the management of pancreatic cancer. (Christians KK, Evans DB) Ann Surg Oncol 2015 Jun;22(6):1755-8 PMID: 25519932
  • Characterization of Anthropometric Changes that Occur During Neoadjuvant Therapy for Potentially Resectable Pancreatic Cancer. (Cooper AB, Slack R, Fogelman D, Holmes HM, Petzel M, Parker N, Balachandran A, Garg N, Ngo-Huang A, Varadhachary G, Evans DB, Lee JE, Aloia T, Conrad C, Vauthey JN, Fleming JB, Katz MH) Ann Surg Oncol 2015 Jul;22(7):2416-23 PMID: 25519927
  • Neoadjuvant chemoradiation with IMRT in resectable and borderline resectable pancreatic cancer. (Kharofa J, Tsai S, Kelly T, Wood C, George B, Ritch P, Wiebe L, Christians K, Evans DB, Erickson B) Radiother Oncol 2014 Oct;113(1):41-6 PMID: 25443499
  • Volume-outcome in cancer surgery: why has the data not affected policy change? (Evans DB, Tsai S) Ann Surg Oncol 2014 Dec;21(13):4056-8 PMID: 25239003
  • Patency rates of portal vein/superior mesenteric vein reconstruction after pancreatectomy for pancreatic cancer. (Krepline AN, Christians KK, Duelge K, Mahmoud A, Ritch P, George B, Erickson BA, Foley WD, Quebbeman EJ, Turaga KK, Johnston FM, Gamblin TC, Evans DB, Tsai S) J Gastrointest Surg 2014 Nov;18(11):2016-25 PMID: 25227638
  • Defining the role of adjuvant external beam radiotherapy on resected adenocarcinoma of the ampulla of vater. (Miura JT, Jayakrishnan TT, Amini A, Johnston FM, Tsai S, Erickson B, Quebbeman EJ, Christians KK, Evans DB, Gamblin TC, Turaga KK) J Gastrointest Surg 2014 Nov;18(11):2003-8 PMID: 25159502
  • Diagnostic laparoscopy should be performed before definitive resection for pancreatic cancer: a financial argument. (Jayakrishnan TT, Nadeem H, Groeschl RT, George B, Thomas JP, Ritch PS, Christians KK, Tsai S, Evans DB, Pappas SG, Gamblin TC, Turaga KK) HPB (Oxford) 2015 Feb;17(2):131-9 PMID: 25123702 PMCID: PMC4299387
  • Surgical resection of synchronously metastatic adrenocortical cancer. (Dy BM, Strajina V, Cayo AK, Richards ML, Farley DR, Grant CS, Harmsen WS, Evans DB, Grubbs EG, Bible KC, Young WF, Perrier ND, Que FG, Nagorney DM, Lee JE, Thompson GB) Ann Surg Oncol 2015 Jan;22(1):146-51 PMID: 25092161
  • A single parathyroid hormone level obtained 4 hours after total thyroidectomy predicts the need for postoperative calcium supplementation. (Carr AA, Yen TW, Fareau GG, Cayo AK, Misustin SM, Evans DB, Wang TS) J Am Coll Surg 2014 Oct;219(4):757-64 PMID: 25053220
  • Chemokines and chemokine receptors: update on utility and challenges for the clinician. (Roy I, Evans DB, Dwinell MB) Surgery 2014 Jun;155(6):961-73 PMID: 24856117 PMCID: PMC4390364
  • Arterial resection at the time of pancreatectomy for cancer. (Christians KK, Pilgrim CH, Tsai S, Ritch P, George B, Erickson B, Tolat P, Evans DB) Surgery 2014 May;155(5):919-26 PMID: 24787115
  • Borderline resectable adrenal cortical carcinoma: a potential role for preoperative chemotherapy. (Bednarski BK, Habra MA, Phan A, Milton DR, Wood C, Vauthey N, Evans DB, Katz MH, Ng CS, Perrier ND, Lee JE, Grubbs EG) World J Surg 2014 Jun;38(6):1318-27 PMID: 24615603
  • CXCL12 chemokine expression suppresses human pancreatic cancer growth and metastasis. (Roy I, Zimmerman NP, Mackinnon AC, Tsai S, Evans DB, Dwinell MB) PLoS One 2014;9(3):e90400 PMID: 24594697 PMCID: PMC3942415
  • Neoadjuvant FOLFIRINOX for borderline resectable pancreas cancer: a new treatment paradigm? (Christians KK, Tsai S, Mahmoud A, Ritch P, Thomas JP, Wiebe L, Kelly T, Erickson B, Wang H, Evans DB, George B) Oncologist 2014 Mar;19(3):266-74 PMID: 24569947 PMCID: PMC3958454
  • Neoadjuvant chemotherapy for localized pancreatic cancer: too little or too long? (White RR, Evans DB) Ann Surg Oncol 2014 May;21(5):1508-9 PMID: 24452411
  • Reply: To PMID 23816382. (Pilgrim CH, Evans DB, Christians KK) J Am Coll Surg 2014 Feb;218(2):307-8 PMID: 24440074
  • Optimal management of the splenic vein at the time of venous resection for pancreatic cancer: importance of the inferior mesenteric vein. (Pilgrim CH, Tsai S, Tolat P, Patel P, Rilling W, Evans DB, Christians KK) J Gastrointest Surg 2014 May;18(5):917-21 PMID: 24347313
  • Treatment sequencing for resectable pancreatic cancer: influence of early metastases and surgical complications on multimodality therapy completion and survival. (Tzeng CW, Tran Cao HS, Lee JE, Pisters PW, Varadhachary GR, Wolff RA, Abbruzzese JL, Crane CH, Evans DB, Wang H, Abbott DE, Vauthey JN, Aloia TA, Fleming JB, Katz MH) J Gastrointest Surg 2014 Jan;18(1):16-24; discussion 24-5 PMID: 24241967
  • Cost analysis of thyroid lobectomy and intraoperative frozen section versus total thyroidectomy in patients with a cytologic diagnosis of "suspicious for papillary thyroid cancer". (Leiker AJ, Yen TW, Cheung K, Evans DB, Wang TS) Surgery 2013 Dec;154(6):1307-13; discussion 1313-4 PMID: 24238049
  • Radiographic tumor-vein interface as a predictor of intraoperative, pathologic, and oncologic outcomes in resectable and borderline resectable pancreatic cancer. (Tran Cao HS, Balachandran A, Wang H, Nogueras-González GM, Bailey CE, Lee JE, Pisters PW, Evans DB, Varadhachary G, Crane CH, Aloia TA, Vauthey JN, Fleming JB, Katz MH) J Gastrointest Surg 2014 Feb;18(2):269-78; discussion 278 PMID: 24129826 PMCID: PMC4016045
  • The utility of routine preoperative cervical ultrasonography in patients undergoing thyroidectomy for differentiated thyroid cancer. (O'Connell K, Yen TW, Quiroz F, Evans DB, Wang TS) Surgery 2013 Oct;154(4):697-701; discussion 701-3 PMID: 24011674
  • Pre-operative ultrasound identification of thyroiditis helps predict the need for thyroid hormone replacement after thyroid lobectomy. (Morris LF, Iupe IM, Edeiken-Monroe BS, Warneke CL, Hansen MO, Evans DB, Lee JE, Grubbs EG, Perrier ND) Endocr Pract 2013 Nov-Dec;19(6):1015-20 PMID: 24013973
  • Borderline resectable/locally advanced pancreatic adenocarcinoma: improvements needed in population-based registries. (Miura JT, Evans DB, Pappas SG, Gamblin TC, Turaga KK) Ann Surg Oncol 2013 Dec;20(13):4338-47 PMID: 24002538
  • Rational study endpoint(s) for preoperative trials in pancreatic cancer: pathologic response rate, margin negative resection, overall survival or 'all of the above'? (Varadhachary GR, Evans DB) Ann Surg Oncol 2013 Nov;20(12):3712-4 PMID: 23943023
  • Mesocaval shunting: a novel technique to facilitate venous resection and reconstruction and enhance exposure of the superior mesenteric and celiac arteries during pancreaticoduodenectomy. (Pilgrim CH, Tsai S, Evans DB, Christians KK) J Am Coll Surg 2013 Sep;217(3):e17-20 PMID: 23816382
  • Factors that influence parathyroid hormone half-life: determining if new intraoperative criteria are needed. (Leiker AJ, Yen TW, Eastwood DC, Doffek KM, Szabo A, Evans DB, Wang TS) JAMA Surg 2013 Jul;148(7):602-6 PMID: 23677330 PMCID: PMC4448959
  • Staging chest computed tomography and positron emission tomography in patients with pancreatic adenocarcinoma: utility or futility? (Pappas SG, Christians KK, Tolat PP, Mautz AP, Lal A, McElroy L, Gamblin TC, Turaga KK, Tsai S, Erickson B, Ritch P, Evans DB) HPB (Oxford) 2014 Jan;16(1):70-4 PMID: 23496023 PMCID: PMC3892317
  • The cost-effectiveness of neoadjuvant chemoradiation is superior to a surgery-first approach in the treatment of pancreatic head adenocarcinoma. (Abbott DE, Tzeng CW, Merkow RP, Cantor SB, Chang GJ, Katz MH, Bentrem DJ, Bilimoria KY, Crane CH, Varadhachary GR, Abbruzzese JL, Wolff RA, Lee JE, Evans DB, Fleming JB) Ann Surg Oncol 2013 Dec;20 Suppl 3:S500-8 PMID: 23397153
  • Focused parathyroidectomy with intraoperative parathyroid hormone monitoring in patients with lithium-associated primary hyperparathyroidism. (Wade TJ, Yen TW, Amin AL, Evans DB, Wilson SD, Wang TS) Surgery 2013 May;153(5):718-22 PMID: 23352236
  • Long-term outcomes of surgical treatment for hereditary pheochromocytoma. (Grubbs EG, Rich TA, Ng C, Bhosale PR, Jimenez C, Evans DB, Lee JE, Perrier ND) J Am Coll Surg 2013 Feb;216(2):280-9 PMID: 23317575
  • Distal splenorenal and temporary mesocaval shunting at the time of pancreatectomy for cancer: initial experience from the Medical College of Wisconsin. (Christians KK, Riggle K, Keim R, Pappas S, Tsai S, Ritch P, Erickson B, Evans DB) Surgery 2013 Jul;154(1):123-31 PMID: 23305596
  • Current staging systems for pancreatic cancer. (Appel BL, Tolat P, Evans DB, Tsai S) Cancer J 2012 Nov-Dec;18(6):539-49 PMID: 23187840
  • Long-term follow-up data may help manage patient and parent expectations for pediatric patients undergoing thyroidectomy. (Morris LF, Waguespack SG, Warneke CL, Ryu H, Ying AK, Anderson BJ, Sturgis EM, Clayman GL, Lee JE, Evans DB, Grubbs EG, Perrier ND) Surgery 2012 Dec;152(6):1165-71 PMID: 23158186
  • Predicting the need for calcium and calcitriol supplementation after total thyroidectomy: results of a prospective, randomized study. (Cayo AK, Yen TW, Misustin SM, Wall K, Wilson SD, Evans DB, Wang TS) Surgery 2012 Dec;152(6):1059-67 PMID: 23068088
  • Is previous same quadrant surgery a contraindication to laparoscopic adrenalectomy? (Mazeh H, Froyshteter AB, Wang TS, Amin AL, Evans DB, Sippel RS, Chen H, Yen TW) Surgery 2012 Dec;152(6):1211-7 PMID: 23068085
  • Novel multimodality treatment sequencing for extrahepatic (mid and distal) cholangiocarcinoma. (Turaga KK, Tsai S, Wiebe LA, Evans DB, Gamblin TC) Ann Surg Oncol 2013 Apr;20(4):1230-9 PMID: 23064778
  • Effect of prophylactic central compartment neck dissection on serum thyroglobulin and recommendations for adjuvant radioactive iodine in patients with differentiated thyroid cancer. (Wang TS, Evans DB, Fareau GG, Carroll T, Yen TW) Ann Surg Oncol 2012 Dec;19(13):4217-22 PMID: 23010732
  • Ultrasonography should not guide the timing of thyroidectomy in pediatric patients diagnosed with multiple endocrine neoplasia syndrome 2A through genetic screening. (Morris LF, Waguespack SG, Edeiken-Monroe BS, Lee JE, Rich TA, Ying AK, Warneke CL, Evans DB, Perrier ND, Grubbs EG) Ann Surg Oncol 2013 Jan;20(1):53-9 PMID: 22890595 PMCID: PMC3892987
  • No need to abandon unilateral parathyroid surgery. (Hodin R, Angelos P, Carty S, Chen H, Clark O, Doherty G, Duh QY, Evans DB, Heller K, Inabnet W, Kebebew E, Pasieka J, Perrier N, Sturgeon C) J Am Coll Surg 2012 Aug;215(2):297; author reply 297-300 PMID: 22818100
  • Critical steps for pancreaticoduodenectomy in the setting of pancreatic adenocarcinoma. (Christians KK, Tsai S, Tolat PP, Evans DB) J Surg Oncol 2013 Jan;107(1):33-8 PMID: 22711619
  • Efficacy and safety of self-expandable metal stents for biliary decompression in patients receiving neoadjuvant therapy for pancreatic cancer: a prospective study. (Aadam AA, Evans DB, Khan A, Oh Y, Dua K) Gastrointest Endosc 2012 Jul;76(1):67-75 PMID: 22483859
  • Outcomes and economic analysis of routine preoperative 4-dimensional CT for surgical intervention in de novo primary hyperparathyroidism: does clinical benefit justify the cost? (Abbott DE, Cantor SB, Grubbs EG, Santora R, Gomez HF, Evans DB, Lee JE, Vu T, Perrier ND) J Am Coll Surg 2012 Apr;214(4):629-37; discussion 637-9 PMID: 22321526
  • Histologic tumor involvement of superior mesenteric vein/portal vein predicts poor prognosis in patients with stage II pancreatic adenocarcinoma treated with neoadjuvant chemoradiation. (Wang J, Estrella JS, Peng L, Rashid A, Varadhachary GR, Wang H, Lee JE, Pisters PW, Vauthey JN, Katz MH, Gomez HF, Evans DB, Abbruzzese JL, Fleming JB, Wang H) Cancer 2012 Aug 1;118(15):3801-11 PMID: 22180096 PMCID: PMC3310937
  • Population-level predictors of persistent hyperparathyroidism. (Perrier ND, Evans DB) Surgery 2011 Dec;150(6):1120-1 PMID: 22136830
  • Achieving eugastrinemia in MEN1 patients: both duodenal inspection and formal lymph node dissection are important. (Dickson PV, Rich TA, Xing Y, Cote GJ, Wang H, Perrier ND, Evans DB, Lee JE, Grubbs EG) Surgery 2011 Dec;150(6):1143-52 PMID: 22136834
  • Papillary carcinoma of the thyroid: balancing principles of oncology with emerging technology. (Evans DB) Surgery 2011 Dec;150(6):1015-22 PMID: 22136816
  • Nonlocalizing imaging studies for hyperparathyroidism: where to explore first? (Amin AL, Wang TS, Wade TJ, Quiroz FA, Hellman RS, Evans DB, Yen TW) J Am Coll Surg 2011 Dec;213(6):793-9 PMID: 22014659
  • Primary hyperparathyroidism with a history of head and neck irradiation: the consequences of associated thyroid tumors. (Wilson SD, Doffek KM, Wang TS, Krzywda EA, Evans DB, Yen TW) Surgery 2011 Oct;150(4):869-77 PMID: 22000202
  • Posterior retroperitoneoscopic adrenalectomy is a safe and effective alternative to transabdominal laparoscopic adrenalectomy for pheochromocytoma. (Dickson PV, Alex GC, Grubbs EG, Ayala-Ramirez M, Jimenez C, Evans DB, Lee JE, Perrier ND) Surgery 2011 Sep;150(3):452-8 PMID: 21878230
  • Post-therapy pathologic stage and survival in patients with pancreatic ductal adenocarcinoma treated with neoadjuvant chemoradiation. (Estrella JS, Rashid A, Fleming JB, Katz MH, Lee JE, Wolf RA, Varadhachary GR, Pisters PW, Abdalla EK, Vauthey JN, Wang H, Gomez HF, Evans DB, Abbruzzese JL, Wang H) Cancer 2012 Jan 1;118(1):268-77 PMID: 21735446
  • Survival and quality of life of patients with resected pancreatic adenocarcinoma treated with adjuvant interferon-based chemoradiation: a phase II trial. (Katz MH, Wolff R, Crane CH, Varadhachary G, Javle M, Lin E, Evans DB, Lee JE, Fleming JB, Pisters PW) Ann Surg Oncol 2011 Dec;18(13):3615-22 PMID: 21701927
  • ALDH activity selectively defines an enhanced tumor-initiating cell population relative to CD133 expression in human pancreatic adenocarcinoma. (Kim MP, Fleming JB, Wang H, Abbruzzese JL, Choi W, Kopetz S, McConkey DJ, Evans DB, Gallick GE) PLoS One 2011;6(6):e20636 PMID: 21695188 PMCID: PMC3113804
  • Posterior retroperitoneoscopic adrenalectomy: a contemporary American experience. (Dickson PV, Jimenez C, Chisholm GB, Kennamer DL, Ng C, Grubbs EG, Evans DB, Lee JE, Perrier ND) J Am Coll Surg 2011 Apr;212(4):659-65; discussion 665-7 PMID: 21463807
  • Adjuvant therapy for pancreatic cancer: a logical strategy in search of progress. (Evans DB, Wolff RA) Ann Surg Oncol 2011 May;18(5):1224-8 PMID: 21384245
  • Do the recent American Thyroid Association (ATA) Guidelines accurately guide the timing of prophylactic thyroidectomy in MEN2A? (Grubbs EG, Waguespack SG, Rich TA, Xing Y, Ying AK, Evans DB, Lee JE, Perrier ND) Surgery 2010 Dec;148(6):1302-9; discussion 1309-10 PMID: 21134565
  • The importance of a multidisciplinary approach to endocrine tumors. (Wang TS, Evans DB) Surgery 2010 Dec;148(6):1311-2 PMID: 21134566
  • Common locations of parathyroid adenomas. (Moreno MA, Callender GG, Woodburn K, Edeiken-Monroe BS, Grubbs EG, Evans DB, Lee JE, Perrier ND) Ann Surg Oncol 2011 Apr;18(4):1047-51 PMID: 21104031
  • Reoperative parathyroidectomy: location of missed glands based on a contemporary nomenclature system. (Silberfein EJ, Bao R, Lopez A, Grubbs EG, Lee JE, Evans DB, Perrier ND) Arch Surg 2010 Nov;145(11):1065-8 PMID: 21079094
  • Metastatic adult granulosa cell tumor mimicking a benign pancreatic cyst. (Abadeer RA, Fleming JB, Deavers MT, Rashid A, Evans DB, Wang H) Ann Diagn Pathol 2010 Dec;14(6):457-60 PMID: 21074697
  • Overexpression of receptor tyrosine kinase Axl promotes tumor cell invasion and survival in pancreatic ductal adenocarcinoma. (Song X, Wang H, Logsdon CD, Rashid A, Fleming JB, Abbruzzese JL, Gomez HF, Evans DB, Wang H) Cancer 2011 Feb 15;117(4):734-43 PMID: 20922806 PMCID: PMC4403266
  • Borderline resectable pancreatic cancer: definitions and the importance of multimodality therapy. (Evans DB, Erickson BA, Ritch P) Ann Surg Oncol 2010 Nov;17(11):2803-5 PMID: 20737218
  • High levels of expression of human stromal cell-derived factor-1 are associated with worse prognosis in patients with stage II pancreatic ductal adenocarcinoma. (Liang JJ, Zhu S, Bruggeman R, Zaino RJ, Evans DB, Fleming JB, Gomez HF, Zander DS, Wang H) Cancer Epidemiol Biomarkers Prev 2010 Oct;19(10):2598-604 PMID: 20732965
  • Multidisciplinary management strategy for incidental cystic lesions of the pancreas. (Bose D, Tamm E, Liu J, Marcal L, Balachandran A, Bhosale P, Fleming JB, Lee JE, Evans DB, Hwang RF) J Am Coll Surg 2010 Aug;211(2):205-15 PMID: 20670858 PMCID: PMC4174396
  • High levels of nucleolar expression of nucleolin are associated with better prognosis in patients with stage II pancreatic ductal adenocarcinoma. (Peng L, Liang J, Wang H, Song X, Rashid A, Gomez HF, Corley LJ, Abbruzzese JL, Fleming JB, Evans DB, Wang H) Clin Cancer Res 2010 Jul 15;16(14):3734-42 PMID: 20628027
  • Adult-onset hypogonadotropic hypogonadism caused by aberrant expression of aromatase in an adrenocortical adenocarcinoma. (Advani A, Johnson SJ, Nicol MR, Papacleovoulou G, Evans DB, Vaikkakara S, Mason JI, Quinton R) Endocr J 2010;57(7):651-6 PMID: 20467160
  • Parathyroidectomy improves functional capacity in "asymptomatic" older patients with primary hyperparathyroidism: a randomized control trial. (Morris GS, Grubbs EG, Hearon CM, Gantela S, Lee JE, Evans DB, Holmes HM, Busaidy NL, Jimenez C, Perrier ND) Ann Surg 2010 May;251(5):832-7 PMID: 20395857
  • Portal vein resection. (Christians KK, Lal A, Pappas S, Quebbeman E, Evans DB) Surg Clin North Am 2010 Apr;90(2):309-22 PMID: 20362788
  • Do practice patterns reflect practice guidelines? (Yen TW, Evans DB) Ann Surg Oncol 2010 Jun;17(6):1478-80 PMID: 20232162
  • Serum CA 19-9 as a marker of resectability and survival in patients with potentially resectable pancreatic cancer treated with neoadjuvant chemoradiation. (Katz MH, Varadhachary GR, Fleming JB, Wolff RA, Lee JE, Pisters PW, Vauthey JN, Abdalla EK, Sun CC, Wang H, Crane CH, Lee JH, Tamm EP, Abbruzzese JL, Evans DB) Ann Surg Oncol 2010 Jul;17(7):1794-801 PMID: 20162463 PMCID: PMC2889288
  • Management of borderline resectable pancreatic cancer. (Lal A, Christians K, Evans DB) Surg Oncol Clin N Am 2010 Apr;19(2):359-70 PMID: 20159519
  • Routine pre-operative ultrasonography for papillary thyroid cancer: effects on cervical recurrence. (Marshall CL, Lee JE, Xing Y, Perrier ND, Edeiken BS, Evans DB, Grubbs EG) Surgery 2009 Dec;146(6):1063-72 PMID: 19958933
  • Anaplastic thyroid cancer: Clinical outcomes with conformal radiotherapy. (Bhatia A, Rao A, Ang KK, Garden AS, Morrison WH, Rosenthal DI, Evans DB, Clayman G, Sherman SI, Schwartz DL) Head Neck 2010 Jul;32(7):829-36 PMID: 19885924
  • Prospective, randomized, controlled trial of parathyroidectomy versus observation in patients with "asymptomatic" primary hyperparathyroidism. (Perrier ND, Balachandran D, Wefel JS, Jimenez C, Busaidy N, Morris GS, Dong W, Jackson E, Weaver S, Gantela S, Evans DB, Grubbs EG, Lee JE) Surgery 2009 Dec;146(6):1116-22 PMID: 19879613
  • Generation of orthotopic and heterotopic human pancreatic cancer xenografts in immunodeficient mice. (Kim MP, Evans DB, Wang H, Abbruzzese JL, Fleming JB, Gallick GE) Nat Protoc 2009;4(11):1670-80 PMID: 19876027 PMCID: PMC4203372
  • Recurrence of adrenal cortical carcinoma following resection: surgery alone can achieve results equal to surgery plus mitotane. (Grubbs EG, Callender GG, Xing Y, Perrier ND, Evans DB, Phan AT, Lee JE) Ann Surg Oncol 2010 Jan;17(1):263-70 PMID: 19851811
  • Posterior retroperitoneoscopic adrenalectomy. (Callender GG, Kennamer DL, Grubbs EG, Lee JE, Evans DB, Perrier ND) Adv Surg 2009;43:147-57 PMID: 19845175
  • TrkBT1 induces liver metastasis of pancreatic cancer cells by sequestering Rho GDP dissociation inhibitor and promoting RhoA activation. (Li Z, Chang Z, Chiao LJ, Kang Y, Xia Q, Zhu C, Fleming JB, Evans DB, Chiao PJ) Cancer Res 2009 Oct 1;69(19):7851-9 PMID: 19773448 PMCID: PMC3087630
  • Clinical significance of distinguishing between follicular lesion and follicular neoplasm in thyroid fine-needle aspiration biopsy. (Williams MD, Suliburk JW, Staerkel GA, Busaidy NL, Clayman GL, Evans DB, Perrier ND) Ann Surg Oncol 2009 Nov;16(11):3146-53 PMID: 19727961
  • Outpatient minimally invasive parathyroidectomy is safe for elderly patients. (Shin SH, Holmes H, Bao R, Jimenez C, Kee SS, Potylchansky E, Lee JE, Evans DB, Perrier ND) J Am Coll Surg 2009 Jun;208(6):1071-6 PMID: 19476894
  • The fallen one: the inferior parathyroid gland that descends into the mediastinum. (Callender GG, Grubbs EG, Vu T, Hofstetter WL, Fleming JB, Woodburn KL, Lee JE, Evans DB, Perrier ND) J Am Coll Surg 2009 May;208(5):887-93; discussion 893-5 PMID: 19476855
  • Medullary thyroid cancer: management guidelines of the American Thyroid Association. (American Thyroid Association Guidelines Task Force, Kloos RT, Eng C, Evans DB, Francis GL, Gagel RF, Gharib H, Moley JF, Pacini F, Ringel MD, Schlumberger M, Wells SA Jr) Thyroid 2009 Jun;19(6):565-612 PMID: 19469690
  • Thyroid cancer in young adults. (Ying AK, Huh W, Bottomley S, Evans DB, Waguespack SG) Semin Oncol 2009 Jun;36(3):258-74 PMID: 19460583
  • Secreted interleukin-1alpha induces a metastatic phenotype in pancreatic cancer by sustaining a constitutive activation of nuclear factor-kappaB. (Melisi D, Niu J, Chang Z, Xia Q, Peng B, Ishiyama S, Evans DB, Chiao PJ) Mol Cancer Res 2009 May;7(5):624-33 PMID: 19435817 PMCID: PMC2856954
  • Surgical treatment of resectable and borderline resectable pancreas cancer: expert consensus statement. (Evans DB, Farnell MB, Lillemoe KD, Vollmer C Jr, Strasberg SM, Schulick RD) Ann Surg Oncol 2009 Jul;16(7):1736-44 PMID: 19387741
  • Influence of obesity on cancer-related outcomes after pancreatectomy to treat pancreatic adenocarcinoma. (Fleming JB, Gonzalez RJ, Petzel MQ, Lin E, Morris JS, Gomez H, Lee JE, Crane CH, Pisters PW, Evans DB) Arch Surg 2009 Mar;144(3):216-21 PMID: 19289659
  • Significant associations of mismatch repair gene polymorphisms with clinical outcome of pancreatic cancer. (Dong X, Jiao L, Li Y, Evans DB, Wang H, Hess KR, Abbruzzese JL, Li D) J Clin Oncol 2009 Apr 1;27(10):1592-9 PMID: 19237629 PMCID: PMC2668967
  • Long-term survival after multidisciplinary management of resected pancreatic adenocarcinoma. (Katz MH, Wang H, Fleming JB, Sun CC, Hwang RF, Wolff RA, Varadhachary G, Abbruzzese JL, Crane CH, Krishnan S, Vauthey JN, Abdalla EK, Lee JE, Pisters PW, Evans DB) Ann Surg Oncol 2009 Apr;16(4):836-47 PMID: 19194760 PMCID: PMC3066077
  • Pancreaticoduodenectomy and vascular resection: persistent controversy and current recommendations. (Christians K, Evans DB) Ann Surg Oncol 2009 Apr;16(4):789-91 PMID: 19169752
  • The integration of chemoradiation in the care of patient with localized pancreatic cancer. (Crane CH, Varadhachary G, Settle SH, Fleming JB, Evans DB, Wolff RA) Cancer Radiother 2009 Apr;13(2):123-43 PMID: 19167921
  • Proteasome-mediated degradation and functions of hematopoietic progenitor kinase 1 in pancreatic cancer. (Wang H, Song X, Logsdon C, Zhou G, Evans DB, Abbruzzese JL, Hamilton SR, Tan TH, Wang H) Cancer Res 2009 Feb 1;69(3):1063-70 PMID: 19141650 PMCID: PMC4403239
  • Postoperative external beam radiotherapy for differentiated thyroid cancer: outcomes and morbidity with conformal treatment. (Schwartz DL, Lobo MJ, Ang KK, Morrison WH, Rosenthal DI, Ahamad A, Evans DB, Clayman G, Sherman SI, Garden AS) Int J Radiat Oncol Biol Phys 2009 Jul 15;74(4):1083-91 PMID: 19095376 PMCID: PMC2745400
  • Anatomy of the superior mesenteric vein with special reference to the surgical management of first-order branch involvement at pancreaticoduodenectomy. (Katz MH, Fleming JB, Pisters PW, Lee JE, Evans DB) Ann Surg 2008 Dec;248(6):1098-102 PMID: 19092356
  • The recognition and surgical management of heritable lesions of the pancreas. (Kim MP, Evans DB, Vu TM, Fleming JB) Surg Oncol Clin N Am 2009 Jan;18(1):99-119, ix PMID: 19056044
  • Treatment options for metastatic neuroendocrine tumors. (Phan AT, Yao JC, Evans DB) Surgery 2008 Dec;144(6):895-8 PMID: 19040994
  • Preoperative vitamin D replacement therapy in primary hyperparathyroidism: safe and beneficial? (Grubbs EG, Rafeeq S, Jimenez C, Feng L, Lee JE, Evans DB, Perrier ND) Surgery 2008 Dec;144(6):852-8; discussion 858-9 PMID: 19040987
  • Polymorphisms of p16, p27, p73, and MDM2 modulate response and survival of pancreatic cancer patients treated with preoperative chemoradiation. (Chen J, Li D, Killary AM, Sen S, Amos CI, Evans DB, Abbruzzese JL, Frazier ML) Ann Surg Oncol 2009 Feb;16(2):431-9 PMID: 19020940
  • Expression of MAP4K4 is associated with worse prognosis in patients with stage II pancreatic ductal adenocarcinoma. (Liang JJ, Wang H, Rashid A, Tan TH, Hwang RF, Hamilton SR, Abbruzzese JL, Evans DB, Wang H) Clin Cancer Res 2008 Nov 1;14(21):7043-9 PMID: 18981001
  • Posterior retroperitoneoscopic adrenalectomy: preferred technique for removal of benign tumors and isolated metastases. (Perrier ND, Kennamer DL, Bao R, Jimenez C, Grubbs EG, Lee JE, Evans DB) Ann Surg 2008 Oct;248(4):666-74 PMID: 18936580
  • Diabetes insipidus and panhypopituitarism due to intrasellar metastasis from medullary thyroid cancer. (Santarpia L, Gagel RF, Sherman SI, Sarlis NJ, Evans DB, Hoff AO) Head Neck 2009 Mar;31(3):419-23 PMID: 18798312
  • Polymorphisms of p21 and p27 jointly contribute to an earlier age at diagnosis of pancreatic cancer. (Chen J, Killary AM, Sen S, Amos CI, Evans DB, Abbruzzese JL, Frazier ML) Cancer Lett 2008 Dec 8;272(1):32-9 PMID: 18694622 PMCID: PMC3780599
  • Cisplatin, fluorouracil, interferon-alpha, and radiation as adjuvant therapy for resected pancreatic cancer: is there a future for this regimen and/or should we change our approach to research and treatment of patients with pancreatic cancer? (Pisters PW, Evans DB) Ann Surg 2008 Aug;248(2):152-3 PMID: 18650622
  • Preoperative gemcitabine-based chemoradiation for patients with resectable adenocarcinoma of the pancreatic head. (Evans DB, Varadhachary GR, Crane CH, Sun CC, Lee JE, Pisters PW, Vauthey JN, Wang H, Cleary KR, Staerkel GA, Charnsangavej C, Lano EA, Ho L, Lenzi R, Abbruzzese JL, Wolff RA) J Clin Oncol 2008 Jul 20;26(21):3496-502 PMID: 18640930
  • Preoperative gemcitabine and cisplatin followed by gemcitabine-based chemoradiation for resectable adenocarcinoma of the pancreatic head. (Varadhachary GR, Wolff RA, Crane CH, Sun CC, Lee JE, Pisters PW, Vauthey JN, Abdalla E, Wang H, Staerkel GA, Lee JH, Ross WA, Tamm EP, Bhosale PR, Krishnan S, Das P, Ho L, Xiong H, Abbruzzese JL, Evans DB) J Clin Oncol 2008 Jul 20;26(21):3487-95 PMID: 18640929
  • Adjuvant therapy for adenocarcinoma of the pancreas: analysis of reported trials and recommendations for future progress. (Wolff RA, Varadhachary GR, Evans DB) Ann Surg Oncol 2008 Oct;15(10):2773-86 PMID: 18612703
  • Diagnosis and management of cystic neoplasms of the pancreas: an evidence-based approach. (Katz MH, Mortenson MM, Wang H, Hwang R, Tamm EP, Staerkel G, Lee JH, Evans DB, Fleming JB) J Am Coll Surg 2008 Jul;207(1):106-20 PMID: 18589369
  • Impact of preoperative thyroid ultrasonography on the surgical management of primary hyperparathyroidism. (Monroe DP, Edeiken-Monroe BS, Lee JE, Evans DB, Perrier ND) Br J Surg 2008 Aug;95(8):957-60 PMID: 18574846
  • Efficacy of 4D-CT preoperative localization in 2 patients with MEN 2A. (Philip M, Guerrero MA, Evans DB, Hunter GJ, Edeiken-Monroe BS, Vu T, Perrier ND) J Surg Educ 2008 May-Jun;65(3):182-5 PMID: 18571130
  • One hundred years after "carcinoid": epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States. (Yao JC, Hassan M, Phan A, Dagohoy C, Leary C, Mares JE, Abdalla EK, Fleming JB, Vauthey JN, Rashid A, Evans DB) J Clin Oncol 2008 Jun 20;26(18):3063-72 PMID: 18565894
  • The added value of multidisciplinary care for patients with pancreatic cancer. (Evans DB, Crane CH, Charnsangavej C, Wolff RA) Ann Surg Oncol 2008 Aug;15(8):2078-80 PMID: 18546044 PMCID: PMC2491408
  • Parathyroid exploration in the reoperative neck: improved preoperative localization with 4D-computed tomography. (Mortenson MM, Evans DB, Lee JE, Hunter GJ, Shellingerhout D, Vu T, Edeiken BS, Feng L, Perrier ND) J Am Coll Surg 2008 May;206(5):888-95; discussion 895-6 PMID: 18471717
  • Borderline resectable pancreatic cancer: the importance of this emerging stage of disease. (Katz MH, Pisters PW, Evans DB, Sun CC, Lee JE, Fleming JB, Vauthey JN, Abdalla EK, Crane CH, Wolff RA, Varadhachary GR, Hwang RF) J Am Coll Surg 2008 May;206(5):833-46; discussion 846-8 PMID: 18471707
  • Current diagnosis and management of unusual pancreatic tumors. (Mortenson MM, Katz MH, Tamm EP, Bhutani MS, Wang H, Evans DB, Fleming JB) Am J Surg 2008 Jul;196(1):100-13 PMID: 18466869
  • Combined EUS with FNA and ERCP for the evaluation of patients with obstructive jaundice from presumed pancreatic malignancy. (Ross WA, Wasan SM, Evans DB, Wolff RA, Trapani LV, Staerkel GA, Prindiville T, Lee JH) Gastrointest Endosc 2008 Sep;68(3):461-6 PMID: 18384788
  • Single-nucleotide polymorphisms of DNA damage response genes are associated with overall survival in patients with pancreatic cancer. (Okazaki T, Jiao L, Chang P, Evans DB, Abbruzzese JL, Li D) Clin Cancer Res 2008 Apr 1;14(7):2042-8 PMID: 18381943 PMCID: PMC2423806
  • Recent advances in thyroid cancer. (Grubbs EG, Rich TA, Li G, Sturgis EM, Younes MN, Myers JN, Edeiken-Monroe B, Fornage BD, Monroe DP, Staerkel GA, Williams MD, Waguespack SG, Hu MI, Cote G, Gagel RF, Cohen J, Weber RS, Anaya DA, Holsinger FC, Perrier ND, Clayman GL, Evans DB) Curr Probl Surg 2008 Mar;45(3):156-250 PMID: 18346477
  • Recent advances in thyroid cancer. In brief. (Grubbs EG, Rich TA, Li G, Sturgis EM, Younes MN, Myers JN, Edeiken-Monroe B, Fornage BD, Monroe DP, Staerkel GA, Williams MD, Waguespack SG, Hu MI, Cote G, Gagel RF, Cohen J, Weber RS, Anaya DA, Holsinger FC, Perrier ND, Clayman GL, Evans DB) Curr Probl Surg 2008 Mar;45(3):149-51 PMID: 18346476
  • Resectable pancreatic cancer: the role for neoadjuvant/preoperative therapy. (Evans DB, Multidisciplinary Pancreatic Cancer Study Group) HPB (Oxford) 2006;8(5):365-8 PMID: 18333089 PMCID: PMC2020747
  • Tumor-node-metastasis staging of pancreatic adenocarcinoma. (Katz MH, Hwang R, Fleming JB, Evans DB) CA Cancer J Clin 2008 Mar-Apr;58(2):111-25 PMID: 18272835
  • Development of an integrated biospecimen bank and multidisciplinary clinical database for pancreatic cancer. (Hwang RF, Wang H, Lara A, Gomez H, Chang T, Sieffert N, Moon Y, Ram S, Zimmerman S, Lee JH, Pisters PW, Tamm EP, Fleming JB, Abbruzzese JL, Evans DB) Ann Surg Oncol 2008 May;15(5):1356-66 PMID: 18256882
  • Cancer-associated stromal fibroblasts promote pancreatic tumor progression. (Hwang RF, Moore T, Arumugam T, Ramachandran V, Amos KD, Rivera A, Ji B, Evans DB, Logsdon CD) Cancer Res 2008 Feb 1;68(3):918-26 PMID: 18245495 PMCID: PMC2519173
  • Viability of cryopreserved parathyroid tissue: when is continued storage versus disposal indicated? (Guerrero MA, Evans DB, Lee JE, Bao R, Bereket A, Gantela S, Griffin GD, Perrier ND) World J Surg 2008 May;32(5):836-9 PMID: 18228092
  • Postoperative radiotherapy for advanced medullary thyroid cancer--local disease control in the modern era. (Schwartz DL, Rana V, Shaw S, Yazbeck C, Ang KK, Morrison WH, Rosenthal DI, Hoff A, Evans DB, Clayman GL, Garden AS, Sherman SI) Head Neck 2008 Jul;30(7):883-8 PMID: 18213725
  • Response to mitotane predicts outcome in patients with recurrent adrenal cortical carcinoma. (Gonzalez RJ, Tamm EP, Ng C, Phan AT, Vassilopoulou-Sellin R, Perrier ND, Evans DB, Lee JE) Surgery 2007 Dec;142(6):867-75; discussion 867-75 PMID: 18063070
  • Same-day ultrasound guidance in reoperations for locally recurrent papillary thyroid cancer. (Solorzano CC, Evans DB) Surgery 2007 Dec;142(6):973-5 PMID: 18063084
  • XRCC2 and XRCC3 gene polymorphism and risk of pancreatic cancer. (Jiao L, Hassan MM, Bondy ML, Wolff RA, Evans DB, Abbruzzese JL, Li D) Am J Gastroenterol 2008 Feb;103(2):360-7 PMID: 17986315 PMCID: PMC2268638
  • Role of adjuvant chemoradiation therapy in adenocarcinomas of the ampulla of vater. (Krishnan S, Rana V, Evans DB, Varadhachary G, Das P, Bhatia S, Delclos ME, Janjan NA, Wolff RA, Crane CH, Pisters PW) Int J Radiat Oncol Biol Phys 2008 Mar 1;70(3):735-43 PMID: 17980502
  • Failure to recognize multiple endocrine neoplasia 2B: more common than we think? (Wray CJ, Rich TA, Waguespack SG, Lee JE, Perrier ND, Evans DB) Ann Surg Oncol 2008 Jan;15(1):293-301 PMID: 17963006
  • Population-based study of islet cell carcinoma. (Yao JC, Eisner MP, Leary C, Dagohoy C, Phan A, Rashid A, Hassan M, Evans DB) Ann Surg Oncol 2007 Dec;14(12):3492-500 PMID: 17896148 PMCID: PMC2077912
  • Risk factors for pancreatic cancer: case-control study. (Hassan MM, Bondy ML, Wolff RA, Abbruzzese JL, Vauthey JN, Pisters PW, Evans DB, Khan R, Chou TH, Lenzi R, Jiao L, Li D) Am J Gastroenterol 2007 Dec;102(12):2696-707 PMID: 17764494 PMCID: PMC2423805
  • Retrospective analysis of dual-phase MDCT and follow-up EUS/EUS-FNA in the diagnosis of pancreatic cancer. (Tamm EP, Loyer EM, Faria SC, Evans DB, Wolff RA, Charnsangavej C) Abdom Imaging 2007 Sep-Oct;32(5):660-7 PMID: 17712589
  • Future chemoradiation strategies in pancreatic cancer. (Crane CH, Varadhachary G, Pisters PW, Evans DB, Wolff RA) Semin Oncol 2007 Aug;34(4):335-46 PMID: 17674962
  • Improvement of sleep disturbance and neurocognitive function after parathyroidectomy in patients with primary hyperparathyroidism. (Mittendorf EA, Wefel JS, Meyers CA, Doherty D, Shapiro SE, Lee JE, Evans DB, Perrier ND) Endocr Pract 2007 Jul-Aug;13(4):338-44 PMID: 17669708
  • Followup of patients with papillary thyroid cancer: in search of the optimal algorithm. (Mittendorf EA, Wang X, Perrier ND, Francis AM, Edeiken BS, Shapiro SE, Lee JE, Evans DB) J Am Coll Surg 2007 Aug;205(2):239-47 PMID: 17660070
  • Role of lymph node dissection in primary surgery for thyroid cancer. (Grubbs EG, Evans DB) J Natl Compr Canc Netw 2007 Jul;5(6):623-30 PMID: 17623613
  • Targeted expression of BikDD eradicates pancreatic tumors in noninvasive imaging models. (Xie X, Xia W, Li Z, Kuo HP, Liu Y, Li Z, Ding Q, Zhang S, Spohn B, Yang Y, Wei Y, Lang JY, Evans DB, Chiao PJ, Abbruzzese JL, Hung MC) Cancer Cell 2007 Jul;12(1):52-65 PMID: 17613436
  • Impact of resection status on pattern of failure and survival after pancreaticoduodenectomy for pancreatic adenocarcinoma. (Raut CP, Tseng JF, Sun CC, Wang H, Wolff RA, Crane CH, Hwang R, Vauthey JN, Abdalla EK, Lee JE, Pisters PW, Evans DB) Ann Surg 2007 Jul;246(1):52-60 PMID: 17592291 PMCID: PMC1899216
  • Pheochromocytoma: advances in genetics, diagnosis, localization, and treatment. (Mittendorf EA, Evans DB, Lee JE, Perrier ND) Hematol Oncol Clin North Am 2007 Jun;21(3):509-25; ix PMID: 17548037
  • Induction chemotherapy selects patients with locally advanced, unresectable pancreatic cancer for optimal benefit from consolidative chemoradiation therapy. (Krishnan S, Rana V, Janjan NA, Varadhachary GR, Abbruzzese JL, Das P, Delclos ME, Gould MS, Evans DB, Wolff RA, Crane CH) Cancer 2007 Jul 1;110(1):47-55 PMID: 17538975
  • Retrospective analysis of dual-phase MDCT and follow-up EUS/EUS-FNA in the diagnosis of pancreatic cancer. (Tamm EP et al.) Abdom Imaging 2007 May 24: PMID: 17522753
  • Patterns of self-reported symptoms in pancreatic cancer patients receiving chemoradiation. (Reyes-Gibby CC, Chan W, Abbruzzese JL, Xiong HQ, Ho L, Evans DB, Varadhachary G, Bhat S, Wolff RA, Crane C) J Pain Symptom Manage 2007 Sep;34(3):244-52 PMID: 17513082 PMCID: PMC2084477
  • The learning curve in pancreatic surgery. (Tseng JF, Pisters PW, Lee JE, Wang H, Gomez HF, Sun CC, Evans DB) Surgery 2007 May;141(5):694-701 PMID: 17511115
  • Aurora-A and p16 polymorphisms contribute to an earlier age at diagnosis of pancreatic cancer in Caucasians. (Chen J, Li D, Wei C, Sen S, Killary AM, Amos CI, Evans DB, Abbruzzese JL, Frazier ML) Clin Cancer Res 2007 May 15;13(10):3100-4 PMID: 17505013 PMCID: PMC2365501
  • Passive smoking and the use of noncigarette tobacco products in association with risk for pancreatic cancer: a case-control study. (Hassan MM, Abbruzzese JL, Bondy ML, Wolff RA, Vauthey JN, Pisters PW, Evans DB, Khan R, Lenzi R, Jiao L, Li D) Cancer 2007 Jun 15;109(12):2547-56 PMID: 17492688 PMCID: PMC2215306
  • Arterial variants in pancreatic adenocarcinoma. (Balachandran A, Darden DL, Tamm EP, Faria SC, Evans DB, Charnsangavej C) Abdom Imaging 2008 Mar-Apr;33(2):214-21 PMID: 17435979
  • Dietary mutagen exposure and risk of pancreatic cancer. (Li D, Day RS, Bondy ML, Sinha R, Nguyen NT, Evans DB, Abbruzzese JL, Hassan MM) Cancer Epidemiol Biomarkers Prev 2007 Apr;16(4):655-61 PMID: 17416754 PMCID: PMC1892159
  • Mechanisms of synthetic serine protease inhibitor (FUT-175)-mediated cell death. (Uwagawa T, Li Z, Chang Z, Xia Q, Peng B, Sclabas GM, Ishiyama S, Hung MC, Evans DB, Abbruzzese JL, Chiao PJ) Cancer 2007 May 15;109(10):2142-53 PMID: 17410536
  • The learning curve in pancreatic surgery. (Tseng JF, Pisters PW, Lee JE, Wang H, Gomez HF, Sun CC, Evans DB) Surgery 2007 Apr;141(4):456-63 PMID: 17383522
  • Elevated expression of vascular endothelial growth factor correlates with increased angiogenesis and decreased progression-free survival among patients with low-grade neuroendocrine tumors. (Zhang J, Jia Z, Li Q, Wang L, Rashid A, Zhu Z, Evans DB, Vauthey JN, Xie K, Yao JC) Cancer 2007 Apr 15;109(8):1478-86 PMID: 17340592
  • Delayed recovery after pancreaticoduodenectomy: a major factor impairing the delivery of adjuvant therapy? (Aloia TA, Lee JE, Vauthey JN, Abdalla EK, Wolff RA, Varadhachary GR, Abbruzzese JL, Crane CH, Evans DB, Pisters PW) J Am Coll Surg 2007 Mar;204(3):347-55 PMID: 17324767
  • Tyrosine kinase receptor RON in human pancreatic cancer: expression, function, and validation as a target. (Camp ER, Yang A, Gray MJ, Fan F, Hamilton SR, Evans DB, Hooper AT, Pereira DS, Hicklin DJ, Ellis LM) Cancer 2007 Mar 15;109(6):1030-9 PMID: 17311308
  • Immunocytochemical study of the expression of mesothelin in fine-needle aspiration biopsy specimens of pancreatic adenocarcinoma. (Baruch AC, Wang H, Staerkel GA, Evans DB, Hwang RF, Krishnamurthy S) Diagn Cytopathol 2007 Mar;35(3):143-7 PMID: 17304533
  • Surgical management of familial hyperparathyroidism. (Evans DB, Rich TA, Cote GJ) Ann Surg Oncol 2007 May;14(5):1525-7 PMID: 17285397
  • Glutathione S-transferase gene polymorphisms and risk and survival of pancreatic cancer. (Jiao L, Bondy ML, Hassan MM, Chang DZ, Abbruzzese JL, Evans DB, Smolensky MH, Li D) Cancer 2007 Mar 1;109(5):840-8 PMID: 17265526 PMCID: PMC1892189
  • Effects of base excision repair gene polymorphisms on pancreatic cancer survival. (Li D, Li Y, Jiao L, Chang DZ, Beinart G, Wolff RA, Evans DB, Hassan MM, Abbruzzese JL) Int J Cancer 2007 Apr 15;120(8):1748-54 PMID: 17230526 PMCID: PMC1892183
  • K-ras mutation and p16 and preproenkephalin promoter hypermethylation in plasma DNA of pancreatic cancer patients: in relation to cigarette smoking. (Jiao L, Zhu J, Hassan MM, Evans DB, Abbruzzese JL, Li D) Pancreas 2007 Jan;34(1):55-62 PMID: 17198183 PMCID: PMC1905887
  • Invited commentary: medullary thyroid cancer: the importance of RET testing. (Evans DB, Shapiro SE, Cote GJ) Surgery 2007 Jan;141(1):96-9 PMID: 17188173
  • On "Posterior retroperitoneoscopic adrenalectomy--results of 560 procedures in 520 patients". (Evans DB, Perrier ND) Surgery 2006 Dec;140(6):951-2 PMID: 17188143
  • Improved preoperative planning for directed parathyroidectomy with 4-dimensional computed tomography. (Rodgers SE, Hunter GJ, Hamberg LM, Schellingerhout D, Doherty DB, Ayers GD, Shapiro SE, Edeiken BS, Truong MT, Evans DB, Lee JE, Perrier ND) Surgery 2006 Dec;140(6):932-40; discussion 940-1 PMID: 17188140
  • Management of thyroid nodules detected at US: Society of Radiologists in Ultrasound consensus conference statement. (Frates MC, Benson CB, Charboneau JW, Cibas ES, Clark OH, Coleman BG, Cronan JJ, Doubilet PM, Evans DB, Goellner JR, Hay ID, Hertzberg BS, Intenzo CM, Jeffrey RB, Langer JE, Larsen PR, Mandel SJ, Middleton WD, Reading CC, Sherman SI, Tessler FN) Ultrasound Q 2006 Dec;22(4):231-8; discussion 239-40 PMID: 17146329
  • Prognostic factors in patients with unresectable locally advanced pancreatic adenocarcinoma treated with chemoradiation. (Krishnan S, Rana V, Janjan NA, Abbruzzese JL, Gould MS, Das P, Delclos ME, Palla S, Guha S, Varadhachary G, Evans DB, Wolff RA, Crane CH) Cancer 2006 Dec 1;107(11):2589-96 PMID: 17083124
  • Concurrent capecitabine and upper abdominal radiation therapy is well tolerated. (Das P, Wolff RA, Abbruzzese JL, Varadhachary GR, Evans DB, Vauthey JN, Baschnagel A, Delclos ME, Krishnan S, Janjan NA, Crane CH) Radiat Oncol 2006;1:41 PMID: 17062148 PMCID: PMC1634749
  • Staging of pancreatic cancer with multidetector CT in the setting of preoperative chemoradiation therapy. (Tamm EP et al.) Abdom Imaging 2006 Sep 12: PMID: 16967235
  • Potential role of Jun activation domain-binding protein 1 as a negative regulator of p27kip1 in pancreatic adenocarcinoma. (Kouvaraki MA, Korapati AL, Rassidakis GZ, Tian L, Zhang Q, Chiao P, Ho L, Evans DB, Claret FX) Cancer Res 2006 Sep 1;66(17):8581-9 PMID: 16951171 PMCID: PMC1780177
  • Regulatory role of c-Met in insulin-like growth factor-I receptor-mediated migration and invasion of human pancreatic carcinoma cells. (Bauer TW, Somcio RJ, Fan F, Liu W, Johnson M, Lesslie DP, Evans DB, Gallick GE, Ellis LM) Mol Cancer Ther 2006 Jul;5(7):1676-82 PMID: 16891453
  • Adrenocortical carcinoma. (Rodgers SE, Evans DB, Lee JE, Perrier ND) Surg Oncol Clin N Am 2006 Jul;15(3):535-53 PMID: 16882496
  • Src activation of Stat3 is an independent requirement from NF-kappaB activation for constitutive IL-8 expression in human pancreatic adenocarcinoma cells. (Trevino JG, Gray MJ, Nawrocki ST, Summy JM, Lesslie DP, Evans DB, Sawyer TK, Shakespeare WC, Watowich SS, Chiao PJ, McConkey DJ, Gallick GE) Angiogenesis 2006;9(2):101-10 PMID: 16871430
  • Borderline resectable pancreatic cancer: definitions, management, and role of preoperative therapy. (Varadhachary GR, Tamm EP, Abbruzzese JL, Xiong HQ, Crane CH, Wang H, Lee JE, Pisters PW, Evans DB, Wolff RA) Ann Surg Oncol 2006 Aug;13(8):1035-46 PMID: 16865597
  • Selected polymorphisms of DNA repair genes and risk of pancreatic cancer. (Jiao L, Bondy ML, Hassan MM, Wolff RA, Evans DB, Abbruzzese JL, Li D) Cancer Detect Prev 2006;30(3):284-91 PMID: 16844323 PMCID: PMC1857309
  • Intraductal papillary mucinous neoplasms of the pancreas. (Al-Refaie WB, Choi EA, Tseng JF, Tamm EP, Lee JH, Lee JE, Evans DB, Pisters PW) Med Princ Pract 2006;15(4):245-52 PMID: 16763389
  • Management of pancreatic endocrine tumors in multiple endocrine neoplasia type 1. (Kouvaraki MA, Shapiro SE, Cote GJ, Lee JE, Yao JC, Waguespack SG, Gagel RF, Evans DB, Perrier ND) World J Surg 2006 May;30(5):643-53 PMID: 16680581
  • Indications for operative intervention in patients with asymptomatic primary hyperparathyroidism: practice patterns of endocrine surgery. (Kouvaraki MA, Greer M, Sharma S, Beery D, Armand R, Lee JE, Evans DB, Perrier ND) Surgery 2006 Apr;139(4):527-34 PMID: 16627063
  • Abdominal visceral lesions in von Hippel-Lindau disease: incidence and clinical behavior of pancreatic and adrenal lesions at a single center. (Delman KA, Shapiro SE, Jonasch EW, Lee JE, Curley SA, Evans DB, Perrier ND) World J Surg 2006 May;30(5):665-9 PMID: 16617420
  • The argument for pre-operative chemoradiation for localized, radiographically resectable pancreatic cancer. (Crane CH, Varadhachary G, Wolff RA, Pisters PW, Evans DB) Best Pract Res Clin Gastroenterol 2006 Apr;20(2):365-82 PMID: 16549333
  • Venous resection in pancreatic cancer surgery. (Tseng JF, Tamm EP, Lee JE, Pisters PW, Evans DB) Best Pract Res Clin Gastroenterol 2006 Apr;20(2):349-64 PMID: 16549332
  • Significant effect of homologous recombination DNA repair gene polymorphisms on pancreatic cancer survival. (Li D, Liu H, Jiao L, Chang DZ, Beinart G, Wolff RA, Evans DB, Hassan MM, Abbruzzese JL) Cancer Res 2006 Mar 15;66(6):3323-30 PMID: 16540687 PMCID: PMC1462866
  • Intraductal papillary mucinous neoplasms of the pancreas: effect of invasion and pancreatic margin status on recurrence and survival. (Raut CP, Cleary KR, Staerkel GA, Abbruzzese JL, Wolff RA, Lee JH, Vauthey JN, Lee JE, Pisters PW, Evans DB) Ann Surg Oncol 2006 Apr;13(4):582-94 PMID: 16523362
  • Single nucleotide polymorphisms of RecQ1, RAD54L, and ATM genes are associated with reduced survival of pancreatic cancer. (Li D, Frazier M, Evans DB, Hess KR, Crane CH, Jiao L, Abbruzzese JL) J Clin Oncol 2006 Apr 10;24(11):1720-8 PMID: 16520463 PMCID: PMC1435378
  • Phase I trial evaluating the safety of bevacizumab with concurrent radiotherapy and capecitabine in locally advanced pancreatic cancer. (Crane CH, Ellis LM, Abbruzzese JL, Amos C, Xiong HQ, Ho L, Evans DB, Tamm EP, Ng C, Pisters PW, Charnsangavej C, Delclos ME, O'Reilly M, Lee JE, Wolff RA) J Clin Oncol 2006 Mar 1;24(7):1145-51 PMID: 16505434
  • Staging of pancreatic cancer with multidetector CT in the setting of preoperative chemoradiation therapy. (Tamm EP, Loyer EM, Faria S, Raut CP, Evans DB, Wolff RA, Crane CH, Dubrow RA, Charnsangavej C) Abdom Imaging 2006 Sep-Oct;31(5):568-74 PMID: 16465578
  • The XPD Asp312Asn and Lys751Gln polymorphisms, corresponding haplotype, and pancreatic cancer risk. (Jiao L, Hassan MM, Bondy ML, Abbruzzese JL, Evans DB, Li D) Cancer Lett 2007 Jan 8;245(1-2):61-8 PMID: 16458430 PMCID: PMC1741855
  • Preoperative chemoradiation for pancreatic cancer. (Evans DB) Semin Oncol 2005 Dec;32(6 Suppl 9):S25-9 PMID: 16399426
  • Carcinoid tumors of the duodenum. (Mullen JT, Wang H, Yao JC, Lee JH, Perrier ND, Pisters PW, Lee JE, Evans DB) Surgery 2005 Dec;138(6):971-7; discussion 977-8 PMID: 16360380
  • Laparoscopic resection of adrenal cortical carcinoma: a cautionary note. (Gonzalez RJ, Shapiro S, Sarlis N, Vassilopoulou-Sellin R, Perrier ND, Evans DB, Lee JE) Surgery 2005 Dec;138(6):1078-85; discussion 1085-6 PMID: 16360394
  • Management of thyroid nodules detected at US: Society of Radiologists in Ultrasound consensus conference statement. (Frates MC, Benson CB, Charboneau JW, Cibas ES, Clark OH, Coleman BG, Cronan JJ, Doubilet PM, Evans DB, Goellner JR, Hay ID, Hertzberg BS, Intenzo CM, Jeffrey RB, Langer JE, Larsen PR, Mandel SJ, Middleton WD, Reading CC, Sherman SI, Tessler FN, Society of Radiologists in Ultrasound) Radiology 2005 Dec;237(3):794-800 PMID: 16304103
  • Pancreaticoduodenectomy after placement of endobiliary metal stents. (Mullen JT, Lee JH, Gomez HF, Ross WA, Fukami N, Wolff RA, Abdalla EK, Vauthey JN, Lee JE, Pisters PW, Evans DB) J Gastrointest Surg 2005 Nov;9(8):1094-104; discussion 1104-5 PMID: 16269380
  • Borderline resectable pancreatic cancer. (Varadhachary GR, Tamm EP, Crane C, Evans DB, Wolff RA) Curr Treat Options Gastroenterol 2005 Oct;8(5):377-84 PMID: 16162303
  • Targeting of urokinase plasminogen activator receptor in human pancreatic carcinoma cells inhibits c-Met- and insulin-like growth factor-I receptor-mediated migration and invasion and orthotopic tumor growth in mice. (Bauer TW, Liu W, Fan F, Camp ER, Yang A, Somcio RJ, Bucana CD, Callahan J, Parry GC, Evans DB, Boyd DD, Mazar AP, Ellis LM) Cancer Res 2005 Sep 1;65(17):7775-81 PMID: 16140945
  • RET proto-oncogene: a review and update of genotype-phenotype correlations in hereditary medullary thyroid cancer and associated endocrine tumors. (Kouvaraki MA, Shapiro SE, Perrier ND, Cote GJ, Gagel RF, Hoff AO, Sherman SI, Lee JE, Evans DB) Thyroid 2005 Jun;15(6):531-44 PMID: 16029119
  • Surgical management of thyroid carcinoma. (Kouvaraki MA, Shapiro SE, Lee JE, Evans DB, Perrier ND) J Natl Compr Canc Netw 2005 May;3(3):458-66 PMID: 16002007
  • Polymorphisms of cytochrome P4501A2 and N-acetyltransferase genes, smoking, and risk of pancreatic cancer. (Li D, Jiao L, Li Y, Doll MA, Hein DW, Bondy ML, Evans DB, Wolff RA, Lenzi R, Pisters PW, Abbruzzese JL, Hassan MM) Carcinogenesis 2006 Jan;27(1):103-11 PMID: 15987714 PMCID: PMC1350610
  • Feasibility of a randomized trial of extended lymphadenectomy for pancreatic cancer. (Pawlik TM, Abdalla EK, Barnett CC, Ahmad SA, Cleary KR, Vauthey JN, Lee JE, Evans DB, Pisters PW) Arch Surg 2005 Jun;140(6):584-9; discussion 589-91 PMID: 15967906
  • Overexpression of neuropilin-1 promotes constitutive MAPK signalling and chemoresistance in pancreatic cancer cells. (Wey JS, Gray MJ, Fan F, Belcheva A, McCarty MF, Stoeltzing O, Somcio R, Liu W, Evans DB, Klagsbrun M, Gallick GE, Ellis LM) Br J Cancer 2005 Jul 25;93(2):233-41 PMID: 15956974 PMCID: PMC2361553
  • Vascular endothelial growth factor receptor-1 promotes migration and invasion in pancreatic carcinoma cell lines. (Wey JS, Fan F, Gray MJ, Bauer TW, McCarty MF, Somcio R, Liu W, Evans DB, Wu Y, Hicklin DJ, Ellis LM) Cancer 2005 Jul 15;104(2):427-38 PMID: 15952180
  • 5,10-Methylenetetrahydrofolate reductase polymorphisms and the risk of pancreatic cancer. (Li D, Ahmed M, Li Y, Jiao L, Chou TH, Wolff RA, Lenzi R, Evans DB, Bondy ML, Pisters PW, Abbruzzese JL, Hassan MM) Cancer Epidemiol Biomarkers Prev 2005 Jun;14(6):1470-6 PMID: 15941958
  • Radiation dose considerations in the palliative treatment of locally advanced adenocarcinoma of the pancreas. (Wong AA, Delclos ME, Wolff RA, Evans DB, Abbruzzese JL, Tamm EP, Xiong HQ, Ho L, Crane CH, Pancreatic Tumor Study Group) Am J Clin Oncol 2005 Jun;28(3):227-33 PMID: 15923793
  • Neuropilin-1 suppresses tumorigenic properties in a human pancreatic adenocarcinoma cell line lacking neuropilin-1 coreceptors. (Gray MJ, Wey JS, Belcheva A, McCarty MF, Trevino JG, Evans DB, Ellis LM, Gallick GE) Cancer Res 2005 May 1;65(9):3664-70 PMID: 15867361
  • Nuclear factor kappa B activation is a potential target for preventing pancreatic carcinoma by aspirin. (Sclabas GM, Uwagawa T, Schmidt C, Hess KR, Evans DB, Abbruzzese JL, Chiao PJ) Cancer 2005 Jun 15;103(12):2485-90 PMID: 15861417
  • Surgical treatment of hyperparathyroidism in patients with multiple endocrine neoplasia type 1. (Lambert LA, Shapiro SE, Lee JE, Perrier ND, Truong M, Wallace MJ, Hoff AO, Gagel RF, Evans DB) Arch Surg 2005 Apr;140(4):374-82 PMID: 15841561
  • Combined-modality treatment for operable pancreatic adenocarcinoma. (Pisters PW, Wolff RA, Crane CH, Evans DB) Oncology (Williston Park) 2005 Mar;19(3):393-404, 409; discussion 409-10, 412-6 PMID: 15828554
  • HIF-1alpha, STAT3, CBP/p300 and Ref-1/APE are components of a transcriptional complex that regulates Src-dependent hypoxia-induced expression of VEGF in pancreatic and prostate carcinomas. (Gray MJ, Zhang J, Ellis LM, Semenza GL, Evans DB, Watowich SS, Gallick GE) Oncogene 2005 Apr 28;24(19):3110-20 PMID: 15735682
  • Surgical treatment of non-functioning pancreatic islet cell tumors. (Kouvaraki MA, Solorzano CC, Shapiro SE, Yao JC, Perrier ND, Lee JE, Evans DB) J Surg Oncol 2005 Mar 1;89(3):170-85 PMID: 15719379
  • Overexpression of tropomysin-related kinase B in metastatic human pancreatic cancer cells. (Sclabas GM, Fujioka S, Schmidt C, Li Z, Frederick WA, Yang W, Yokoi K, Evans DB, Abbruzzese JL, Hess KR, Zhang W, Fidler IJ, Chiao PJ) Clin Cancer Res 2005 Jan 15;11(2 Pt 1):440-9 PMID: 15701826
  • Preventable reoperations for persistent and recurrent papillary thyroid carcinoma. (Kouvaraki MA, Lee JE, Shapiro SE, Sherman SI, Evans DB) Surgery 2004 Dec;136(6):1183-91 PMID: 15657574
  • Pancreaticoduodenectomy with vascular resection: margin status and survival duration. (Tseng JF, Raut CP, Lee JE, Pisters PW, Vauthey JN, Abdalla EK, Gomez HF, Sun CC, Crane CH, Wolff RA, Evans DB) J Gastrointest Surg 2004 Dec;8(8):935-49; discussion 949-50 PMID: 15585381
  • Fluorouracil, doxorubicin, and streptozocin in the treatment of patients with locally advanced and metastatic pancreatic endocrine carcinomas. (Kouvaraki MA, Ajani JA, Hoff P, Wolff R, Evans DB, Lozano R, Yao JC) J Clin Oncol 2004 Dec 1;22(23):4762-71 PMID: 15570077
  • Neoadjuvant therapy for resectable pancreatic cancer. (Raut CP, Evans DB, Crane CH, Pisters PW, Wolff RA) Surg Oncol Clin N Am 2004 Oct;13(4):639-61, ix PMID: 15350939
  • Pheochromocytoma and medullary thyroid carcinoma: a new genotype-phenotype correlation of the RET protooncogene 891 germline mutation. (Jimenez C, Habra MA, Huang SC, El-Naggar A, Shapiro SE, Evans DB, Cote G, Gagel RF) J Clin Endocrinol Metab 2004 Aug;89(8):4142-5 PMID: 15292360
  • Parathyroid carcinoma: a 22-year experience. (Busaidy NL, Jimenez C, Habra MA, Schultz PN, El-Naggar AK, Clayman GL, Asper JA, Diaz EM Jr, Evans DB, Gagel RF, Garden A, Hoff AO, Lee JE, Morrison WH, Rosenthal DI, Sherman SI, Sturgis EM, Waguespack SG, Weber RS, Wirfel K, Vassilopoulou-Sellin R) Head Neck 2004 Aug;26(8):716-26 PMID: 15287039
  • A novel point mutation of the RET protooncogene involving the second intracellular tyrosine kinase domain in a family with medullary thyroid carcinoma. (Jimenez C, Dang GT, Schultz PN, El-Naggar A, Shapiro S, Barnes EA, Evans DB, Vassilopoulou-Sellin R, Gagel RF, Cote GJ, Hoff AO) J Clin Endocrinol Metab 2004 Jul;89(7):3521-6 PMID: 15240641
  • Surgical and endoscopic palliation for pancreatic cancer. (Andtbacka RH, Evans DB, Pisters PW) Minerva Chir 2004 Apr;59(2):123-36 PMID: 15238887
  • Overexpression of synuclein-gamma in pancreatic adenocarcinoma. (Li Z, Sclabas GM, Peng B, Hess KR, Abbruzzese JL, Evans DB, Chiao PJ) Cancer 2004 Jul 1;101(1):58-65 PMID: 15221989
  • Fine-needle aspiration cytology of mucinous tumors of the pancreas. (Recine M, Kaw M, Evans DB, Krishnamurthy S) Cancer 2004 Apr 25;102(2):92-9 PMID: 15098253
  • Surgical management of hereditary pheochromocytoma. (Yip L, Lee JE, Shapiro SE, Waguespack SG, Sherman SI, Hoff AO, Gagel RF, Arens JF, Evans DB) J Am Coll Surg 2004 Apr;198(4):525-34; discussion 534-5 PMID: 15051000
  • The role of intraoperative radiotherapy in pancreatic cancer. (Crane CH, Beddar AS, Evans DB) Surg Oncol Clin N Am 2003 Oct;12(4):965-77 PMID: 14989127
  • Inhibition of platelet-derived growth factor receptor phosphorylation by STI571 (Gleevec) reduces growth and metastasis of human pancreatic carcinoma in an orthotopic nude mouse model. (Hwang RF, Yokoi K, Bucana CD, Tsan R, Killion JJ, Evans DB, Fidler IJ) Clin Cancer Res 2003 Dec 15;9(17):6534-44 PMID: 14695158
  • Potential role for intraoperative gamma probe identification of normal parathyroid glands. (Pederson LC, Shapiro SE, Fritsche HA Jr, Delpassand ES, Gagel RF, Sherman SI, Vassilopoulou-Sellin R, Evans DB, Lee JE) Am J Surg 2003 Dec;186(6):711-7 PMID: 14672784
  • Fine-needle aspiration of the thyroid and correlation with histopathology in a contemporary series of 240 patients. (Sclabas GM, Staerkel GA, Shapiro SE, Fornage BD, Sherman SI, Vassillopoulou-Sellin R, Lee JE, Evans DB) Am J Surg 2003 Dec;186(6):702-9; discussion 709-10 PMID: 14672783
  • Medullary thyroid carcinoma: results of a standardized surgical approach in a contemporary series of 80 consecutive patients. (Yen TW, Shapiro SE, Gagel RF, Sherman SI, Lee JE, Evans DB) Surgery 2003 Dec;134(6):890-9; discussion 899-901 PMID: 14668720
  • Role of preoperative ultrasonography in the surgical management of patients with thyroid cancer. (Kouvaraki MA, Shapiro SE, Fornage BD, Edeiken-Monro BS, Sherman SI, Vassilopoulou-Sellin R, Lee JE, Evans DB) Surgery 2003 Dec;134(6):946-54; discussion 954-5 PMID: 14668727
  • Mechanisms of proinflammatory cytokine-induced biphasic NF-kappaB activation. (Schmidt C, Peng B, Li Z, Sclabas GM, Fujioka S, Niu J, Schmidt-Supprian M, Evans DB, Abbruzzese JL, Chiao PJ) Mol Cell 2003 Nov;12(5):1287-300 PMID: 14636585
  • The role of genetics in the surgical management of familial endocrinopathy syndromes. (Shapiro SE, Cote GC, Lee JE, Gagel RF, Evans DB) J Am Coll Surg 2003 Nov;197(5):818-31 PMID: 14585420
  • Regulation of hypoxia-inducible factor-1alpha, vascular endothelial growth factor, and angiogenesis by an insulin-like growth factor-I receptor autocrine loop in human pancreatic cancer. (Stoeltzing O, Liu W, Reinmuth N, Fan F, Parikh AA, Bucana CD, Evans DB, Semenza GL, Ellis LM) Am J Pathol 2003 Sep;163(3):1001-11 PMID: 12937141 PMCID: PMC1868239
  • Expression and regulation of the novel vascular endothelial growth factor receptor neuropilin-1 by epidermal growth factor in human pancreatic carcinoma. (Parikh AA, Liu WB, Fan F, Stoeltzing O, Reinmuth N, Bruns CJ, Bucana CD, Evans DB, Ellis LM) Cancer 2003 Aug 15;98(4):720-9 PMID: 12910515
  • NF-kappaB in pancreatic cancer. (Sclabas GM, Fujioka S, Schmidt C, Evans DB, Chiao PJ) Int J Gastrointest Cancer 2003;33(1):15-26 PMID: 12909735
  • Novel applications of endo GIA linear staplers during pancreaticoduodenectomy and total pancreatectomy. (Evans DB, Pisters PW) Am J Surg 2003 Jun;185(6):606-7 PMID: 12781900
  • Administration of optimal biological dose and schedule of interferon alpha combined with gemcitabine induces apoptosis in tumor-associated endothelial cells and reduces growth of human pancreatic carcinoma implanted orthotopically in nude mice. (Solorzano CC, Hwang R, Baker CH, Bucana CD, Pisters PW, Evans DB, Killion JJ, Fidler IJ) Clin Cancer Res 2003 May;9(5):1858-67 PMID: 12738744
  • Diagnosis, staging, and surveillance of pancreatic cancer. (Tamm EP, Silverman PM, Charnsangavej C, Evans DB) AJR Am J Roentgenol 2003 May;180(5):1311-23 PMID: 12704043
  • Multiple endocrine neoplasia type 2: evaluation of the genotype-phenotype relationship. (Yip L, Cote GJ, Shapiro SE, Ayers GD, Herzog CE, Sellin RV, Sherman SI, Gagel RF, Lee JE, Evans DB) Arch Surg 2003 Apr;138(4):409-16; discussion 416 PMID: 12686527
  • Comment and perspective on Sewnath and colleagues' recent meta-analysis of the efficacy of preoperative biliary drainage for tumors causing obstructive jaundice. (Pisters PW, Lee JE, Vauthey JN, Evans DB) Ann Surg 2003 Apr;237(4):594-5; author reply 595-6 PMID: 12677158 PMCID: PMC1514484
  • Overexpression of oncogenic STK15/BTAK/Aurora A kinase in human pancreatic cancer. (Li D, Zhu J, Firozi PF, Abbruzzese JL, Evans DB, Cleary K, Friess H, Sen S) Clin Cancer Res 2003 Mar;9(3):991-7 PMID: 12631597
  • Inhibition of constitutive NF-kappa B activity by I kappa B alpha M suppresses tumorigenesis. (Fujioka S, Sclabas GM, Schmidt C, Niu J, Frederick WA, Dong QG, Abbruzzese JL, Evans DB, Baker C, Chiao PJ) Oncogene 2003 Mar 6;22(9):1365-70 PMID: 12618762
  • Diagnostic accuracy of endoscopic ultrasound-guided fine-needle aspiration in patients with presumed pancreatic cancer. (Raut CP, Grau AM, Staerkel GA, Kaw M, Tamm EP, Wolff RA, Vauthey JN, Lee JE, Pisters PW, Evans DB) J Gastrointest Surg 2003 Jan;7(1):118-26; discussion 127-8 PMID: 12559193
  • Restoring apoptosis in pancreatic cancer cells by targeting the nuclear factor-kappaB signaling pathway with the anti-epidermal growth factor antibody IMC-C225. (Sclabas GM, Fujioka S, Schmidt C, Fan Z, Evans DB, Chiao PJ) J Gastrointest Surg 2003 Jan;7(1):37-43; discussion 43 PMID: 12559183
  • Pancreatic leak after left pancreatectomy is reduced following main pancreatic duct ligation. (Bilimoria MM, Cormier JN, Mun Y, Lee JE, Evans DB, Pisters PW) Br J Surg 2003 Feb;90(2):190-6 PMID: 12555295
  • Phase I study of concomitant gemcitabine and IMRT for patients with unresectable adenocarcinoma of the pancreatic head. (Crane CH, Antolak JA, Rosen II, Forster KM, Evans DB, Janjan NA, Charnsangavej C, Pisters PW, Lenzi R, Papagikos MA, Wolff RA) Int J Gastrointest Cancer 2001;30(3):123-32 PMID: 12540024
  • Function of nuclear factor kappaB in pancreatic cancer metastasis. (Fujioka S, Sclabas GM, Schmidt C, Frederick WA, Dong QG, Abbruzzese JL, Evans DB, Baker C, Chiao PJ) Clin Cancer Res 2003 Jan;9(1):346-54 PMID: 12538487
  • Subaquatic laparoscopy for staging of intraabdominal malignancy. (Abdalla EK, Barnett CC, Pisters PW, Cleary KR, Evans DB, Feig BW, Mansfield PF) J Am Coll Surg 2003 Jan;196(1):155-8 PMID: 12517569
  • Improving the yield of preoperative parathyroid localization: technetium Tc 99m-sestamibi imaging after thyroid suppression. (Royal RE, Delpassand ES, Shapiro SE, Fritsche HA Jr, Vassilopoulou-Sellin R, Sherman SI, Gagel RF, Evans DB, Lee JE) Surgery 2002 Dec;132(6):968-74; discussion 974-5 PMID: 12490843
  • Suppression of tumorigenesis and induction of p15(ink4b) by Smad4/DPC4 in human pancreatic cancer cells. (Peng B, Fleming JB, Breslin T, Grau AM, Fojioka S, Abbruzzese JL, Evans DB, Ayers D, Wathen K, Wu T, Robertson KD, Chiao PJ) Clin Cancer Res 2002 Nov;8(11):3628-38 PMID: 12429655
  • ESPAC-1 trial of adjuvant therapy for resectable adenocarcinoma of the pancreas. (Evans DB, Hess KR, Pisters PW) Ann Surg 2002 Nov;236(5):694; author reply 694-6 PMID: 12409677 PMCID: PMC1422632
  • The function of multiple IkappaB : NF-kappaB complexes in the resistance of cancer cells to Taxol-induced apoptosis. (Dong QG, Sclabas GM, Fujioka S, Schmidt C, Peng B, Wu T, Tsao MS, Evans DB, Abbruzzese JL, McDonnell TJ, Chiao PJ) Oncogene 2002 Sep 19;21(42):6510-9 PMID: 12226754
  • Phase II study of docetaxel in patients with pancreatic cancer previously untreated with cytotoxic chemotherapy. (Lenzi R, Yalcin S, Evans DB, Abbruzzese JL) Cancer Invest 2002;20(4):464-72 PMID: 12094541
  • Genotype-phenotype analysis in multiple endocrine neoplasia type 1. (Kouvaraki MA, Lee JE, Shapiro SE, Gagel RF, Sherman SI, Sellin RV, Cote GJ, Evans DB) Arch Surg 2002 Jun;137(6):641-7 PMID: 12049533
  • Preoperative paclitaxel and concurrent rapid-fractionation radiation for resectable pancreatic adenocarcinoma: toxicities, histologic response rates, and event-free outcome. (Pisters PW, Wolff RA, Janjan NA, Cleary KR, Charnsangavej C, Crane CN, Lenzi R, Vauthey JN, Lee JE, Abbruzzese JL, Evans DB) J Clin Oncol 2002 May 15;20(10):2537-44 PMID: 12011133
  • Is the therapeutic index better with gemcitabine-based chemoradiation than with 5-fluorouracil-based chemoradiation in locally advanced pancreatic cancer? (Crane CH, Abbruzzese JL, Evans DB, Wolff RA, Ballo MT, Delclos M, Milas L, Mason K, Charnsangavej C, Pisters PW, Lee JE, Lenzi R, Vauthey JN, Wong AB, Phan T, Nguyen Q, Janjan NA) Int J Radiat Oncol Biol Phys 2002 Apr 1;52(5):1293-302 PMID: 11955742
  • Localized adenocarcinoma of the pancreas: the rationale for preoperative chemoradiation. (Wayne JD, Abdalla EK, Wolff RA, Crane CH, Pisters PW, Evans DB) Oncologist 2002;7(1):34-45 PMID: 11854545
  • Nonfunctioning islet cell carcinoma of the pancreas: survival results in a contemporary series of 163 patients. (Solorzano CC, Lee JE, Pisters PW, Vauthey JN, Ayers GD, Jean ME, Gagel RF, Ajani JA, Wolff RA, Evans DB) Surgery 2001 Dec;130(6):1078-85 PMID: 11742342
  • Evaluation and surgical resection of adrenal masses in patients with a history of extra-adrenal malignancy. (Lenert JT, Barnett CC Jr, Kudelka AP, Sellin RV, Gagel RF, Prieto VG, Skibber JM, Ross MI, Pisters PW, Curley SA, Evans DB, Lee JE) Surgery 2001 Dec;130(6):1060-7 PMID: 11742339
  • Optimal treatment strategy in patients with papillary thyroid cancer: a decision analysis. (Esnaola NF, Cantor SB, Sherman SI, Lee JE, Evans DB) Surgery 2001 Dec;130(6):921-30 PMID: 11742318
  • Adrenal cortical carcinoma. (Dackiw AP, Lee JE, Gagel RF, Evans DB) World J Surg 2001 Jul;25(7):914-26 PMID: 11572033
  • Toxicity and efficacy of concurrent gemcitabine and radiotherapy for locally advanced pancreatic cancer. (Crane CH, Janjan NA, Evans DB, Wolff RA, Ballo MT, Milas L, Mason K, Charnsangavej C, Pisters PW, Lee JE, Lenzi R, Vauthey JN, Wong A, Phan T, Nguyen Q, Abbruzzese JL) Int J Pancreatol 2001;29(1):9-18 PMID: 11560155
  • Combining gemcitabine with radiation in pancreatic cancer: understanding important variables influencing the therapeutic index. (Crane CH, Wolff RA, Abbruzzese JL, Evans DB, Milas L, Mason K, Charnsangavej C, Pisters PW, Lee JE, Lenzi R, Lahoti S, Vauthey JN, Janjan NA) Semin Oncol 2001 Jun;28(3 Suppl 10):25-33 PMID: 11510031
  • Multimodality management of localized pancreatic cancer. (Wayne JD, Wolff RA, Pisters PW, Evans DB) Cancer J 2001 Jul-Aug;7 Suppl 1:S35-46 PMID: 11504284
  • Phase I trial of gemcitabine combined with radiation for the treatment of locally advanced pancreatic adenocarcinoma. (Wolff RA, Evans DB, Gravel DM, Lenzi R, Pisters PW, Lee JE, Janjan NA, Charnsangavej C, Abbruzzese JL) Clin Cancer Res 2001 Aug;7(8):2246-53 PMID: 11489798
  • Preoperative chemoradiation therapy for pancreatic cancer. (Evans DB, Pisters PW) Surg Clin North Am 2001 Jun;81(3):709-13 PMID: 11459284
  • Neoadjuvant strategies for pancreatic cancer. (Evans DB, Wolff RA, Crane CH) Oncology (Williston Park) 2001 Jun;15(6):727-37; discussion 741-4, 747 PMID: 11430206
  • Effect of preoperative biliary decompression on pancreaticoduodenectomy-associated morbidity in 300 consecutive patients. (Pisters PW, Hudec WA, Hess KR, Lee JE, Vauthey JN, Lahoti S, Raijman I, Evans DB) Ann Surg 2001 Jul;234(1):47-55 PMID: 11420482 PMCID: PMC1421947
  • Preoperative chemoradiation for resectable and locally advanced adenocarcinoma of the pancreas. (Evans DB) J Gastrointest Surg 2001 Jan-Feb;5(1):2-5 PMID: 11370617
  • Re: Surgery for ductal adenocarcinoma of the pancreatic head. (Pisters PW, Evans DB, Leung DH, Brennan MF) World J Surg 2001 Apr;25(4):533-4 PMID: 11344412
  • Laparoscopy in the staging of pancreatic cancer. (Pisters PW, Lee JE, Vauthey JN, Charnsangavej C, Evans DB) Br J Surg 2001 Mar;88(3):325-37 PMID: 11260096
  • Neoadjuvant chemoradiotherapy for adenocarcinoma of the pancreas: treatment variables and survival duration. (Breslin TM, Hess KR, Harbison DB, Jean ME, Cleary KR, Dackiw AP, Wolff RA, Abbruzzese JL, Janjan NA, Crane CH, Vauthey JN, Lee JE, Pisters PW, Evans DB) Ann Surg Oncol 2001 Mar;8(2):123-32 PMID: 11258776
  • Limitations of size as a criterion in the evaluation of adrenal tumors. (Barnett CC Jr, Varma DG, El-Naggar AK, Dackiw AP, Porter GA, Pearson AS, Kudelka AP, Gagel RF, Evans DB, Lee JE) Surgery 2000 Dec;128(6):973-82;discussion 982-3 PMID: 11114632
  • Adjuvant radiotherapy and 5-fluorouracil after curative resection of cancer of the pancreas and periampullary region. (Evans DB, Wolff RA, Hess KR) Ann Surg 2000 Nov;232(5):727 PMID: 11066157 PMCID: PMC1421239
  • Cost and utilization impact of a clinical pathway for patients undergoing pancreaticoduodenectomy. (Porter GA, Pisters PW, Mansyur C, Bisanz A, Reyna K, Stanford P, Lee JE, Evans DB) Ann Surg Oncol 2000 Aug;7(7):484-9 PMID: 10947015
  • The detection of telomerase activity in patients with adenocarcinoma of the pancreas by fine needle aspiration. (Pearson AS, Chiao P, Zhang L, Zhang W, Larry L, Katz RL, Evans DB, Abbruzzese JL) Int J Oncol 2000 Aug;17(2):381-5 PMID: 10891550
  • Thyroid cancer: 1999 update. (Tyler DS, Shaha AR, Udelsman RA, Sherman SI, Thompson NW, Moley JF, Evans DB) Ann Surg Oncol 2000 Jun;7(5):376-98 PMID: 10864346
  • Significance and management of local recurrences and limited metastatic disease in the abdomen. (Windham TC, Pearson AS, Skibber JM, Mansfield PF, Lee JE, Pisters PW, Evans DB) Surg Clin North Am 2000 Apr;80(2):761-74, xii PMID: 10836016
  • Current approaches and future strategies for pancreatic carcinoma. (Wolff RA, Chiao P, Lenzi R, Pisters PW, Lee JE, Janjan NA, Crane CH, Evans DB, Abbruzzese JL) Invest New Drugs 2000 Feb;18(1):43-56 PMID: 10830140
  • Gut peptide receptor expression in human pancreatic cancers. (Ehlers RA, Kim Sh, Zhang Y, Ethridge RT, Murrilo C, Hellmich MR, Evans DB, Townsend CM Jr, Mark Evers B) Ann Surg 2000 Jun;231(6):838-48 PMID: 10816627 PMCID: PMC1421073
  • Epidermal growth factor receptor blockade with C225 plus gemcitabine results in regression of human pancreatic carcinoma growing orthotopically in nude mice by antiangiogenic mechanisms. (Bruns CJ, Harbison MT, Davis DW, Portera CA, Tsan R, McConkey DJ, Evans DB, Abbruzzese JL, Hicklin DJ, Radinsky R) Clin Cancer Res 2000 May;6(5):1936-48 PMID: 10815919
  • Relative contributions of technetium Tc 99m sestamibi scintigraphy, intraoperative gamma probe detection, and the rapid parathyroid hormone assay to the surgical management of hyperparathyroidism. (Dackiw AP, Sussman JJ, Fritsche HA Jr, Delpassand ES, Stanford P, Hoff A, Gagel RF, Evans DB, Lee JE) Arch Surg 2000 May;135(5):550-5; discussion 555-7 PMID: 10807279
  • Preoperative chemoradiation for patients with pancreatic cancer: toxicity of endobiliary stents. (Pisters PW, Hudec WA, Lee JE, Raijman I, Lahoti S, Janjan NA, Rich TA, Crane CH, Lenzi R, Wolff RA, Abbruzzese JL, Evans DB) J Clin Oncol 2000 Feb;18(4):860-7 PMID: 10673529
  • Five novel mutations in the familial multiple endocrine neoplasia type 1 (MEN1) gene. Mutations in brief no. 188. Online. (Cote GJ, Lee JE, Evans DB, Huang E, Schultz PN, Dang GT, Qiu H, Shetelbine S, Sellin RV, Gagel RF) Hum Mutat 1998;12(3):219 PMID: 10660339
  • Surgical oncology. (Evans DB) J Am Coll Surg 2000 Feb;190(2):215-26 PMID: 10656559
  • A multispecialty approach to the diagnosis and management of pancreatic cancer. (Hawes RH, Xiong Q, Waxman I, Chang KJ, Evans DB, Abbruzzese JL) Am J Gastroenterol 2000 Jan;95(1):17-31 PMID: 10638554
  • ATP site-directed competitive and irreversible inhibitors of protein kinases. (García-Echeverría C, Traxler P, Evans DB) Med Res Rev 2000 Jan;20(1):28-57 PMID: 10608920
  • Screening for MEN1 mutations in patients with atypical endocrine neoplasia. (Dackiw AP, Cote GJ, Fleming JB, Schultz PN, Stanford P, Vassilopoulou-Sellin R, Evans DB, Gagel RF, Lee JE) Surgery 1999 Dec;126(6):1097-103; discussion 1103-4 PMID: 10598193
  • Enhanced staging and all chemotherapy preoperatively in patients with potentially resectable gastric carcinoma. (Ajani JA, Mansfield PF, Lynch PM, Pisters PW, Feig B, Dumas P, Evans DB, Raijman I, Hargraves K, Curley S, Ota DM) J Clin Oncol 1999 Aug;17(8):2403-11 PMID: 10561303
  • Surgical strategy for the treatment of medullary thyroid carcinoma. (Fleming JB, Lee JE, Bouvet M, Schultz PN, Sherman SI, Sellin RV, Friend KE, Burgess MA, Cote GJ, Gagel RF, Evans DB) Ann Surg 1999 Nov;230(5):697-707 PMID: 10561095 PMCID: PMC1420925
  • Prognostic factors in resectable pancreatic cancer: p53 and bcl-2. (Bold RJ, Hess KR, Pearson AS, Grau AM, Sinicrope FA, Jennings M, McConkey DJ, Bucana CD, Cleary KR, Hallin PA, Chiao PJ, Abbruzzese JL, Evans DB) J Gastrointest Surg 1999 May-Jun;3(3):263-77 PMID: 10481119
  • Major vascular resection as part of pancreaticoduodenectomy for cancer: radiologic, intraoperative, and pathologic analysis. (Bold RJ, Charnsangavej C, Cleary KR, Jennings M, Madray A, Leach SD, Abbruzzese JL, Pisters PW, Lee JE, Evans DB) J Gastrointest Surg 1999 May-Jun;3(3):233-43 PMID: 10481116
  • Overexpression of urokinase-type plasminogen activator in pancreatic adenocarcinoma is regulated by constitutively activated RelA. (Wang W, Abbruzzese JL, Evans DB, Chiao PJ) Oncogene 1999 Aug 12;18(32):4554-63 PMID: 10467400
  • Tumor suppressor gene Smad4/DPC4, its downstream target genes, and regulation of cell cycle. (Chiao PJ, Hunt KK, Grau AM, Abramian A, Fleming J, Zhang W, Breslin T, Abbruzzese JL, Evans DB) Ann N Y Acad Sci 1999 Jun 30;880:31-7 PMID: 10415848
  • Chemoradiation for localized pancreatic cancer: another perspective. (Evans DB, Abbruzzese JL) Ann Surg Oncol 1999 Jan-Feb;6(1):4-7 PMID: 10030405
  • The nuclear factor-kappa B RelA transcription factor is constitutively activated in human pancreatic adenocarcinoma cells. (Wang W, Abbruzzese JL, Evans DB, Larry L, Cleary KR, Chiao PJ) Clin Cancer Res 1999 Jan;5(1):119-27 PMID: 9918209
  • Relative expression of E-cadherin and type IV collagenase genes predicts disease outcome in patients with resectable pancreatic carcinoma. (Kuniyasu H, Ellis LM, Evans DB, Abbruzzese JL, Fenoglio CJ, Bucana CD, Cleary KR, Tahara E, Fidler IJ) Clin Cancer Res 1999 Jan;5(1):25-33 PMID: 9918199
  • The surgical treatment of medullary thyroid carcinoma. (Evans DB, Fleming JB, Lee JE, Cote G, Gagel RF) Semin Surg Oncol 1999 Jan-Feb;16(1):50-63 PMID: 9890740
  • Preoperative chemoradiation strategies for localized adenocarcinoma of the pancreas. (Evans DB, Pisters PW, Lee JE, Bold RJ, Charnsangavej C, Janjan NA, Wolff RA, Abbruzzese JL) J Hepatobiliary Pancreat Surg 1998;5(3):242-50 PMID: 9880770
  • Adenovirus-mediated wild-type p53 tumor suppressor gene therapy induces apoptosis and suppresses growth of human pancreatic cancer [seecomments]. (Bouvet M, Bold RJ, Lee J, Evans DB, Abbruzzese JL, Chiao PJ, McConkey DJ, Chandra J, Chada S, Fang B, Roth JA) Ann Surg Oncol 1998 Dec;5(8):681-8 PMID: 9869513
  • Overexpression of the tumor suppressor gene Smad4/DPC4 induces p21waf1 expression and growth inhibition in human carcinoma cells. (Hunt KK, Fleming JB, Abramian A, Zhang L, Evans DB, Chiao PJ) Cancer Res 1998 Dec 15;58(24):5656-61 PMID: 9865717
  • Unknown primary cancer presenting as an adrenal mass: frequency and implications for diagnostic evaluation of adrenal incidentalomas. (Lee JE, Evans DB, Hickey RC, Sherman SI, Gagel RF, Abbruzzese MC, Abbruzzese JL) Surgery 1998 Dec;124(6):1115-22 PMID: 9854592
  • Rapid-fractionation preoperative chemoradiation, pancreaticoduodenectomy, and intraoperative radiation therapy for resectable pancreatic adenocarcinoma. (Pisters PW, Abbruzzese JL, Janjan NA, Cleary KR, Charnsangavej C, Goswitz MS, Rich TA, Raijman I, Wolff RA, Lenzi R, Lee JE, Evans DB) J Clin Oncol 1998 Dec;16(12):3843-50 PMID: 9850029
  • Gene therapy and pancreatic cancer. (Pearson AS, Bouvet M, Evans DB, Roth JA) Front Biosci 1998 Nov 1;3:E230-7 PMID: 9792901
  • Neoadjuvant chemoradiation for adenocarcinoma of the pancreas. (Breslin TM, Janjan NA, Lee JE, Pisters PW, Wolff RA, Abbruzzese JL, Evans DB) Front Biosci 1998 Nov 1;3:E193-203 PMID: 9792895
  • Preoperative chemoradiation and pancreaticoduodenectomy for adenocarcinoma of the pancreas. (Miller AR, Pisters PW, Lee JE, Janjan NA, Abbruzzese JL, Evans DB) Hepatogastroenterology 1998 May-Jun;45(21):624-33 PMID: 9684107
  • Survival following pancreaticoduodenectomy with resection of the superior mesenteric-portal vein confluence for adenocarcinoma of the pancreatic head. (Leach SD, Lee JE, Charnsangavej C, Cleary KR, Lowy AM, Fenoglio CJ, Pisters PW, Evans DB) Br J Surg 1998 May;85(5):611-7 PMID: 9635805
  • Cell cycle regulation of human pancreatic cancer by tamoxifen. (Robinson EK, Grau AM, Evans DB, Smid CM, Chiao PJ, Abbruzzese JL, Grimm EA) Ann Surg Oncol 1998 Jun;5(4):342-9 PMID: 9641456
  • Vessel counts and vascular endothelial growth factor expression in pancreatic adenocarcinoma. (Ellis LM, Takahashi Y, Fenoglio CJ, Cleary KR, Bucana CD, Evans DB) Eur J Cancer 1998 Feb;34(3):337-40 PMID: 9640218
  • Primary pancreatic lymphoma. (Bouvet M, Staerkel GA, Spitz FR, Curley SA, Charnsangavej C, Hagemeister FB, Janjan NA, Pisters PW, Evans DB) Surgery 1998 Apr;123(4):382-90 PMID: 9551063
  • Neoadjuvant chemoradiation for adenocarcinoma of the pancreas. (Miller AR, Robinson EK, Lee JE, Pisters PW, Chiao PJ, Lenzi RL, Abbruzzese JL, Evans DB) Surg Oncol Clin N Am 1998 Jan;7(1):183-97 PMID: 9443995
  • DNA adducts in human pancreatic tissues and their potential role in carcinogenesis. (Wang M, Abbruzzese JL, Friess H, Hittelman WN, Evans DB, Abbruzzese MC, Chiao P, Li D) Cancer Res 1998 Jan 1;58(1):38-41 PMID: 9426054
  • Neoadjuvant chemoradiation for extrahepatic cholangiocarcinoma. (McMasters KM, Tuttle TM, Leach SD, Rich T, Cleary KR, Evans DB, Curley SA) Am J Surg 1997 Dec;174(6):605-8; discussion 608-9 PMID: 9409582
  • Prospective, randomized trial of octreotide to prevent pancreatic fistula after pancreaticoduodenectomy for malignant disease. (Lowy AM, Lee JE, Pisters PW, Davidson BS, Fenoglio CJ, Stanford P, Jinnah R, Evans DB) Ann Surg 1997 Nov;226(5):632-41 PMID: 9389397 PMCID: PMC1191125
  • Induction of p21waf1 expression and growth inhibition by transforming growth factor beta involve the tumor suppressor gene DPC4 in human pancreatic adenocarcinoma cells. (Grau AM, Zhang L, Wang W, Ruan S, Evans DB, Abbruzzese JL, Zhang W, Chiao PJ) Cancer Res 1997 Sep 15;57(18):3929-34 PMID: 9307274
  • Evaluation of the incidental adrenal mass. (Lee JE, Evans DB, Sherman SI, Gagel RF) Am J Med 1997 Sep;103(3):249-50 PMID: 9316558
  • Pancreatic cancer surgical practice guidelines. Pancreatic Cancer Practice Guideline Committee. (Evans DB, Jessup JM, Colacchio T) Oncology (Williston Park) 1997 Jul;11(7):1074-9 PMID: 9251127
  • Gastric cancer surgical practice guidelines. Gastric Cancer Practice Guideline Committee. (Evans DB, Jessup JM, Colacchio T) Oncology (Williston Park) 1997 Jul;11(7):1067-72 PMID: 9251126
  • Detection of mutated c-Ki-ras in the bile of patients with pancreatic cancer. (Abbruzzese JL, Evans DB, Raijman I, Larry L, King T, Leach SD, Frazier ML) Anticancer Res 1997 Mar-Apr;17(2A):795-801 PMID: 9137410
  • The multidisciplinary structured clinical instruction module as a vehicle for cancer education. (Sloan DA, Donnelly MB, Schwartz RW, Plymale MA, Strodel WE, Kenady DE, McGrath PC, Edwards MJ, Singletary SE, Evans DB, Souba WW, Bland KI) Am J Surg 1997 Mar;173(3):220-5 PMID: 9124631
  • Preoperative and postoperative chemoradiation strategies in patients treated with pancreaticoduodenectomy for adenocarcinoma of the pancreas. (Spitz FR, Abbruzzese JL, Lee JE, Pisters PW, Lowy AM, Fenoglio CJ, Cleary KR, Janjan NA, Goswitz MS, Rich TA, Evans DB) J Clin Oncol 1997 Mar;15(3):928-37 PMID: 9060530
  • Advances in the diagnosis and treatment of gastrointestinal neuroendocrine tumors. (Lee JE, Evans DB) Cancer Treat Res 1997;90:227-38 PMID: 9367086
  • Advances in the diagnosis and treatment of adenocarcinoma of the pancreas. (Evans DB, Lee JE, Pisters PW, Charnsangavej C, Ellis LM, Chiao PJ, Lenzi R, Abbruzzese JL) Cancer Treat Res 1997;90:109-25 PMID: 9367080
  • Medullary thyroid carcinoma. (Evans DB, Burgess MA, Goepfert H, Gagel RF) Curr Ther Endocrinol Metab 1997;6:127-32 PMID: 9174720
  • bcl-2 and p53 expression in resectable pancreatic adenocarcinomas: association with clinical outcome. (Sinicrope FA, Evans DB, Leach SD, Cleary KR, Fenoglio CJ, Lee JJ, Abbruzzese JL) Clin Cancer Res 1996 Dec;2(12):2015-22 PMID: 9816161
  • Cortical-sparing adrenalectomy for patients with bilateral pheochromocytoma. (Lee JE, Curley SA, Gagel RF, Evans DB, Hickey RC) Surgery 1996 Dec;120(6):1064-70; discussion 1070-1 PMID: 8957496
  • Reoperative pancreaticoduodenectomy for periampullary carcinoma. (Robinson EK, Lee JE, Lowy AM, Fenoglio CJ, Pisters PW, Evans DB) Am J Surg 1996 Nov;172(5):432-7; discussion 437-8 PMID: 8942539
  • Relevance of RET proto-oncogene mutations in sporadic medullary thyroid carcinoma. (Wohllk N, Cote GJ, Bugalho MM, Ordonez N, Evans DB, Goepfert H, Khorana S, Schultz P, Richards CS, Gagel RF) J Clin Endocrinol Metab 1996 Oct;81(10):3740-5 PMID: 8855832
  • Association of gastric adenocarcinoma with the HLA class II gene DQB10301. (Lee JE, Lowy AM, Thompson WA, Lu M, Loflin PT, Skibber JM, Evans DB, Curley SA, Mansfield PF, Reveille JD) Gastroenterology 1996 Aug;111(2):426-32 PMID: 8690208
  • The need for standardized pathologic staging of pancreaticoduodenectomy specimens. (Staley CA, Cleary KR, Abbruzzese JL, Lee JE, Ames FC, Fenoglio CJ, Evans DB) Pancreas 1996 May;12(4):373-80 PMID: 8740405
  • Molecular diagnosis of exocrine pancreatic cancer using a percutaneous technique. (Evans DB, Frazier ML, Charnsangavej C, Katz RL, Larry L, Abbruzzese JL) Ann Surg Oncol 1996 May;3(3):241-6 PMID: 8726178
  • Vascular involvement in pancreatic adenocarcinoma: reassessment by thin-section CT. (Loyer EM, David CL, Dubrow RA, Evans DB, Charnsangavej C) Abdom Imaging 1996 May-Jun;21(3):202-6 PMID: 8661548
  • Application of genetic screening information to the management of medullary thyroid carcinoma and multiple endocrine neoplasia type 2. (Wohllk N, Cote GJ, Evans DB, Goepfert H, Ordonez NG, Gagel RF) Endocrinol Metab Clin North Am 1996 Mar;25(1):1-25 PMID: 8907678
  • Pancreatic adenocarcinoma cell line, MDAPanc-28, with features of both acinar and ductal cells. (Frazier ML, Fernández E, de Llorens R, Brown NM, Pathak S, Cleary KR, Abbruzzese JL, Berry K, Olive M, Le Maistre A, Evans DB) Int J Pancreatol 1996 Feb;19(1):31-8 PMID: 8656025
  • Rationale for en bloc vein resection in the treatment of pancreatic adenocarcinoma adherent to the superior mesenteric-portal vein confluence. Pancreatic Tumor Study Group. (Fuhrman GM, Leach SD, Staley CA, Cusack JC, Charnsangavej C, Cleary KR, El-Naggar AK, Fenoglio CJ, Lee JE, Evans DB) Ann Surg 1996 Feb;223(2):154-62 PMID: 8597509 PMCID: PMC1235091
  • Alternative method for exposure of the retropancreatic mesenteric vasculature during total pancreatectomy. (Leach SD, Davidson BS, Ames FC, Evans DB) J Surg Oncol 1996 Feb;61(2):163-5 PMID: 8606551
  • Vascular resection and intraoperative radiation therapy during pancreaticoduodenectomy: rationale and technique. (Evans DB, Lee JE, Leach SD, Fuhrman GM, Cusack JC Jr, Rich TA) Adv Surg 1996;29:235-62 PMID: 8720006
  • Preoperative chemoradiation, pancreaticoduodenectomy, and intraoperative radiation therapy for adenocarcinoma of the pancreatic head. (Staley CA, Lee JE, Cleary KR, Abbruzzese JL, Fenoglio CJ, Rich TA, Evans DB) Am J Surg 1996 Jan;171(1):118-24; discussion 124-5 PMID: 8554125
  • Surgical management, DNA content, and patient survival in adrenal cortical carcinoma. (Lee JE, Berger DH, el-Naggar AK, Hickey RC, Vassilopoulou-Sellin R, Gagel RF, Burgess MA, Evans DB) Surgery 1995 Dec;118(6):1090-8 PMID: 7491528
  • Preoperative chemoradiation for adenocarcinoma of the pancreas: excessive toxicity of prophylactic hepatic irradiation. (Evans DB, Abbruzzese JL, Cleary KR, Buchholz DJ, Fenoglio CJ, Collier C, Rich TA) Int J Radiat Oncol Biol Phys 1995 Nov 1;33(4):913-8 PMID: 7591902
  • Clinical use of molecular information in the management of multiple endocrine neoplasia type 2A. (Gagel RF, Cote GJ, Martins Bugalho MJ, Boyd AE 3rd, Cummings T, Goepfert H, Evans DB, Cangir A, Khorana S, Schultz PN) J Intern Med 1995 Oct;238(4):333-41 PMID: 7595169
  • Significance of peritoneal cytology in patients with potentially resectable adenocarcinoma of the pancreatic head. (Leach SD, Rose JA, Lowy AM, Lee JE, Charnsangavej C, Abbruzzese JL, Katz RL, Evans DB) Surgery 1995 Sep;118(3):472-8 PMID: 7652681
  • Preoperative combined modality therapy for pancreatic cancer. (Rich TA, Evans DB) World J Surg 1995 Mar-Apr;19(2):264-9 PMID: 7754633
  • Fine needle aspiration of the pancreas. In quest of accuracy. (Robins DB, Katz RL, Evans DB, Atkinson EN, Green L) Acta Cytol 1995 Jan-Feb;39(1):1-10 PMID: 7846994
  • Indeterminate fine-needle aspiration biopsy of the thyroid: identification of subgroups at high risk for invasive carcinoma. (Tyler DS, Winchester DJ, Caraway NP, Hickey RC, Evans DB) Surgery 1994 Dec;116(6):1054-60 PMID: 7985087
  • Resection for cure of carcinoma of the colon directly invading the duodenum or pancreatic head. (Curley SA, Evans DB, Ames FC) J Am Coll Surg 1994 Nov;179(5):587-92 PMID: 7952464
  • Managing unsuspected tumor invasion of the superior mesenteric-portal venous confluence during pancreaticoduodenectomy. (Cusack JC Jr, Fuhrman GM, Lee JE, Evans DB) Am J Surg 1994 Oct;168(4):352-4 PMID: 7943594
  • Adrenal medullary disease in multiple endocrine neoplasia type 2. Appropriate management. (Evans DB, Lee JE, Merrell RC, Hickey RC) Endocrinol Metab Clin North Am 1994 Mar;23(1):167-76 PMID: 7913023
  • Reoperative pancreaticoduodenectomy. (Tyler DS, Evans DB) Ann Surg 1994 Feb;219(2):211-21 PMID: 7907464 PMCID: PMC1243124
  • Fine-needle aspiration of pancreatic extramedullary plasmacytoma: possible confusion with islet cell tumor. (Dodd LG, Evans DB, Symmans F, Katz RL) Diagn Cytopathol 1994;10(4):371-4; discussion 374-5 PMID: 7924813
  • Thin-section contrast-enhanced computed tomography accurately predicts the resectability of malignant pancreatic neoplasms. (Fuhrman GM, Charnsangavej C, Abbruzzese JL, Cleary KR, Martin RG, Fenoglio CJ, Evans DB) Am J Surg 1994 Jan;167(1):104-11; discussion 111-3 PMID: 7906097
  • Adjuvant radiotherapy and chemotherapy for biliary and pancreatic cancer. (Rich TA, Evans DB, Curley SA, Ajani JA) Ann Oncol 1994;5 Suppl 3:75-80 PMID: 8204533
  • Nonfunctioning islet cell carcinoma of the pancreas. (Evans DB, Skibber JM, Lee JE, Cleary KR, Ajani JA, Gagel RF, Sellin RV, Fenoglio CJ, Merrell RC, Hickey RC) Surgery 1993 Dec;114(6):1175-81; discussion 1181-2 PMID: 7903005
  • Isolated splenic metastases from colon carcinoma. (Thomas SM, Fitzgerald JB, Pollock RE, Evans DB) Eur J Surg Oncol 1993 Oct;19(5):485-90 PMID: 8405487
  • Extramedullary plasmacytoma of the pancreas. (Davidson BS, Lee JE, Dodd LG, Dimopoulos MA, Evans DB) Am J Clin Oncol 1993 Aug;16(4):363-8 PMID: 8328417
  • Intraoperative radiation therapy following pancreaticoduodenectomy. (Evans DB, Termuhlen PM, Byrd DR, Ames FC, Ochran TG, Rich TA) Ann Surg 1993 Jul;218(1):54-60 PMID: 8101073 PMCID: PMC1242900
  • Feeding jejunostomy techniques. (Ota DM, Evans DB) Surgery 1993 May;113(5):598 PMID: 8488485
  • Preoperative chemoradiation and pancreaticoduodenectomy for adenocarcinoma of the pancreas. (Evans DB, Rich TA, Byrd DR, Cleary KR, Connelly JH, Levin B, Charnsangavej C, Fenoglio CJ, Ames FC) Arch Surg 1992 Nov;127(11):1335-9 PMID: 1359851
  • Laparoscopic feeding jejunostomy tube in oncology patients. (Ellis LM, Evans DB, Martin D, Ota DM) Surg Oncol 1992 Jun;1(3):245-9 PMID: 1341257
  • Human cell line from an adenocarcinoma of the ampulla of Vater. (Frazier ML, Brown N, Pathak S, Mackay B, Cleary K, Olive M, Byrd DR, Evans DB, Levin B) In Vitro Cell Dev Biol 1992 Mar;28A(3 Pt 1):149-53 PMID: 1582987
  • Use of Dexon Mesh for abdominal partitioning above the peritoneal reflection. (Evans DB, Shumate CR, Ames FC, Rich TA) Dis Colon Rectum 1991 Sep;34(9):833-5 PMID: 1914752
  • Preoperative chemoradiotherapy for adenocarcinoma of the pancreas. Rationale and technique. (Evans DB, Byrd DR, Mansfield PF) Am J Clin Oncol 1991 Aug;14(4):359-64 PMID: 1862769
  • Oncocytic adrenal cortical carcinoma. (el-Naggar AK, Evans DB, Mackay B) Ultrastruct Pathol 1991 Jul-Oct;15(4-5):549-56 PMID: 1755111
  • Adenocarcinoma of the pancreas: current management of resectable and locally advanced disease. (Evans DB, Rich TA, Byrd DR, Ames FC) South Med J 1991 May;84(5):566-70 PMID: 2035074
  • Last update: 06/17/2015